A Role For Reactive Oxygen Species In Photodynamic Therapy by Price, Michael
Wayne State University
Wayne State University Dissertations
1-1-2012
A Role For Reactive Oxygen Species In
Photodynamic Therapy
Michael Price
Wayne State University,
Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations
This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in
Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Price, Michael, "A Role For Reactive Oxygen Species In Photodynamic Therapy" (2012). Wayne State University Dissertations. Paper
613.
A ROLE FOR REACTIVE OXYGEN SPECIES IN PHOTODYNAMIC THERAPY 
by 
MICHAEL PRICE 
DISSERTATION 
Submitted to the Graduate School 
of Wayne State University, 
Detroit, Michigan 
in partial fulfillment of the requirements 
for the degree of 
DOCTOR OF PHILOSOPHY  
2012 
MAJOR: CANCER BIOLOGY 
Approved by: 
________________________________________ 
Advisor        Date 
________________________________________ 
________________________________________ 
________________________________________ 
________________________________________ 
© COPYRIGHT BY 
MICHAEL PRICE 
2012 
All Rights Reserved 
	  ii 
DEDICATION 
 I dedicate this work to my family, whose support got me through my studies and 
work.  I would also like to thank all the teachers and professors from my past who 
instilled the meaning of hard work and dedication to learning in me.  Most of all I would 
like to thank my wife, Aimee, and my son, Thadeus, not only all their support and 
motivation but especially for their endless patience with me in this endeavour. 
  
	  iii 
ACKNOWLEDGEMENTS 
I would like to acknowledge Dr. David Kessel, my mentor, not just for the help 
and support in my graduate studies but most importantly for his guidance in my 
development and maturity as a researcher.  
 I would next like to give my deepest appreciation and gratitude to Ann Marie 
Santiago, a research assistant in Dr. Kessel’s laboratory.  She taught me many valuable 
techniques and assisted me on many experiments in the lab.  To my fellow Cancer 
Biology students and the program faculty I would like to give many thanks for their 
support and encouragement over the years.  I would also like to thank Drs. Rasheeda 
Zafar and Joseph Dunbar for their invaluable mentorship. 
 Finally, I would like to acknowledge the members of my dissertation committee 
for all the guidance and encouragement they gave me throughout the years on my 
dissertation.  My greatest appreciation to Drs. Stanley Terlecky, John Reiners Jr., 
Raymond Mattingly, and Hyeong-Reh Kim.  
	  iv 
TABLE OF CONTENTS 
Dedication...... .................................................................................................................. ii 
Acknowledgements .......................................................................................................... iii 
List of Tables... ................................................................................................................ vi 
List of Figures. ................................................................................................................. vii 
List of Abbreviations ....................................................................................................... viii 
CHAPTER 1 – INTRODUCTION ...................................................................................... 1 
1.1 PHOTODYNAMIC THERAPY: INTRODUCTION AND BACKGROUND ................... 1 
1.2 HYPOTHESIS ............................................................................................................ 9 
1.3 AIMS......... ............................................................................................................... 10 
CHAPTER 2 – USE OF FLUORESCENT PROBES FOR DETECTING ROS & RNS ... 12 
2.1 INTRODUCTION ...................................................................................................... 12 
2.2 MATERIALS AND METHODS ................................................................................. 12 
2.3 RESULTS AND DISCUSSION ................................................................................. 14 
2.4 CONCLUSIONS ....................................................................................................... 18 
CHAPTER 3 – MONITORING 1O2 AND •OH FORMATION .......................................... 19 
3.1 INTRODUCTION ...................................................................................................... 19 
3.2 MATERIALS AND METHODS ................................................................................. 19 
3.3 RESULTS AND DISCUSSION ................................................................................. 23 
3.4 CONCLUSIONS ....................................................................................................... 29 
CHAPTER 4 – A ROLE FOR HYDROGEN PEROXIDE IN THE EFFICACY OF 
PHOTODYNAMIC THERAPY ................................................................. 31 
4.1 INTRODUCTION ...................................................................................................... 31 
4.2 MATERIALS AND METHODS ................................................................................. 32 
4.3 RESULTS AND DISCUSSION ................................................................................. 37 
4.4 CONCLUSIONS ....................................................................................................... 43 
	  v 
CHAPTER 5 – EVALUATION OF DIETHYL-3-3’-(9,10-ANTHRACENEDIYL)BIS 
ACRYLATE AS A PROBE FOR SINGLET OXYGEN FORMATION 
DURING PHOTODYNAMIC THERAPY .................................................. 47 
5.1 INTRODUCTION ...................................................................................................... 47 
5.2 MATERIALS AND METHODS ................................................................................. 48 
5.3 RESULTS AND DISCUSSION ................................................................................. 50 
5.4 CONCLUSIONS ....................................................................................................... 54 
CHAPTER 6 – WST11 AND NPe6: EFFECTS OF OXYGENATION LEVELS ON 
PHOTOSENSITIZING EFFICACY .......................................................... 56 
6.1 INTRODUCTION ...................................................................................................... 56 
6.2 MATERIALS AND METHODS ................................................................................. 57 
6.3 RESULTS AND DISCUSSION ................................................................................. 59 
6.4 CONCLUSIONS ....................................................................................................... 63 
CHAPTER 7 – SUMMARY ............................................................................................. 65 
Appendix.…… ................................................................................................................ 68 
References…. ................................................................................................................ 69 
Abstract……… ............................................................................................................... 81 
Autobiographical Statement ........................................................................................... 84 
  
  
	  vi 
LIST OF TABLES 
Table 2.1 Probe:ROS interactions              15 
Table 3.1 Fluorogenic responses of APF and HPF to hydroxyl radical in cell- 
free system                21 
Table 3.2 Morphometric analysis of Figure 3.4             28 
Table 4.1 Effects of CATSKL and 3-AT on PDT efficacy           39 
Table 4.2 ImageJ analysis of caspases-3 activation            41 
Table 4.3 ImageJ analysis of catalase protein             41 
 
	  vii 
LIST OF FIGURES 
Figure 1.1 Type I and II ROS formation during PDT            10 
Figure 2.1 Phase contrast and fluorescence images of P388 cells incubated and 
irradiated with BPD + DAF              17 
Figure 3.1 Structures of HPF and APF              20 
Figure 3.2 Monitoring singlet oxygen formation with SOSG           25 
Figure 3.3 Fluorogenic responses of APF and HPF to singlet oxygen         26 
Figure 3.4 Fluorescence images of APF fluorescence using L1210 cells  
photosensitized by BPD              28 
Figure 4.1 Clonogenic analysis of P388 cells photosensitized with BPD and  
irradiated at varying light doses             37 
Figure 4.2 Fluorescence microscopy demonstrating the localization of BPD        38 
Figure 4.3 Localization of BPD in P388 cells             40 
Figure 4.4 Western blot showing activation of caspase-3 in cells photosensitized  
with BPD ± 3-AT               40 
Figure 4.5 Western blot for catalase after treatment with CATSKL          41 
Figure 4.6 Fluorogenic effect of PDT on DHR             42 
Figure 5.1 Phase-contrast and fluorescence images showing the localization of  
DADB in 1c1c7 cells               51 
Figure 5.2 Fluorescence of intracellular DADB             51 
Figure 5.3 Effect of ROS formation on DADB fluorescence           52 
Figure 5.4 DADB oxidation by singlet oxygen             53 
Figure 6.1 Clonogenic analyses of 1c1c7 cells photosensitized with WST11  
and NPe6                59 
Figure 6.2 Photobleaching of NPe6 and WST11            61 
Figure 6.3 Photobleaching and ROS formation             62 
 
	  viii 
LIST OF ABBREVIATIONS 
APF   3’(p-aminophenyl) fluorescein  
3-AT  3-amino-1,2,4-triazole 
BIP  2,2’-bipyridyl 
BPD  benzoporphyrin derivative (Verteporfin) 
CATSKL catalase-SKL 
CCD  charged couple device 
ClO−  hypochlorite ion  
CPO   9-capronyloxy-tetrakis(methoxyethyl) porphycene 
DADB  diethyl-3-3’-(9,10-anthracenediyl)bis acrylate 
DAF  4’,5’-diaminofluorescein 
DCF   2’,7’-dichlorofluorescein  
DEANO diethylamine nitric oxide 
DFO  desferroxamine 
DHE  dihydroethidine 
DHR  dihydrorhodamine 
DMSO dimethyl sulfoxide 
ER  endoplasmic reticulum 
ESR  electron spin resonance 
Fe(NH4)SO4 ferrous ammonium sulfate (FAS) 
H2O2  hydrogen peroxide 
H2SO4 sulfuric acid 
HA14-1 2-amino-6-bromo-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic 
acid ethyl ester 
HIF1-α  hypoxia inducible factor1-alpha 
HO33342 Hoechest dye 33342 
	  ix 
HPF   3’(p-hydroxyphenyl) fluorescein  
HPD  hematoporphyrin derivative 
HRP  horseradish peroxidase 
KO2  potassium superoxide 
LDL   low density lipoprotein 
LuTex  lutetium texaphyrin 
mTHPC  meta(tetrahydroxyphenyl)chlorin (Foscan)  
NPe6  mono-L-aspartyl chlorin e6 
1O2  singlet oxygen 
•O2-  superoxide anion  
ONOO− peroxynitrite ion 
•OH  hydroxyl radical 
PDT  photodynamic therapy 
Pc4  phthalocyanine 4  
RNS  reactive nitrogen species 
ROS  reactive oxygen species 
RPCI  Roswell Park Cancer Institute 
SnET2 tin etiopurpurin  
SOD  superoxide dismutase 
SOSG  singlet oxygen sensor green 
TiOSO4 titanium oxysulfate 
TMPyP 5,10,15,20-tetrakis (N-methyl-4-pyridyl)-21H,23H 
TPPS  porphine tetra(p-phenylsulfonate) 
1 
 
CHAPTER 1 - INTRODUCTION 
1.1 PHOTODYNAMIC THERAPY: INTRODUCTION AND BACKGROUND 
The term ‘photodynamic therapy’ was invented in the early 1900s by Hermann 
von Tappeiner.  This relates to the ability of reactive oxygen species, formed during 
irradiation of ‘photosensitizers’ to exert lethal effects on living cells.  The process 
involves an interaction between light, oxygen and a chemical compound with 
appropriate photochemical properties and structure.  The effect had been known for 
centuries; one of the earliest uses of a photodynamic effect had been the use of light for 
the bleaching of linen, a process that can be traced back to the early Egyptians, Indians, 
and Chinese over thirty centuries ago (Dolmans, Fukumura et al. 2003; Moan and Peng 
2003).  The ability of certain dyes to sensitize microorganisms to light was first reported 
by Oscar Raab, a medical student at the Pharmacological Institute of Munich, in 1900 
(Dolmans, Fukumura et al. 2003).  This phenomenon was periodically re-discovered 
during the next 50 years, but the modern era of photodynamic therapy, as a procedure 
for cancer therapy, did not begin until 1960 (Dougherty, Gomer et al. 1998).  Sam 
Schwartz and Richard Lipson, two physicians at the Mayo Clinic, had begun a study of 
the ability of a crude hematoporphyrin preparation to localize in neoplastic tissues, as 
determined by fluorescence under ultraviolet light.  Schwartz later empirically developed 
an optimized formulation based on the treatment of crude hematoporphyrin with a 
mixture of acetic and sulfuric acids, followed by neutralization.  He termed the product 
"hematoporphyrin derivative" (HPD).  This turned out to be a superior tumor-localizing 
product, but there was little progress until the work of Thomas Dougherty's group at the 
Roswell Park Cancer Institute (RPCI) in the early 1970s. 
Dougherty was exploring a series of agents proposed to be radiation sensitizers.  
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During the course of this work, he consulted with Dr. Schwartz who reported that 
porphyrins could sensitize malignant cells and tissues to both radiation and light.  
Dougherty persuaded a group of physicians at RPCI to initiate a collaborative project 
involving the potential use of HPD + light for cancer control.  This work resulted in 
evidence that HPD administered to tumor-bearing animals or cancer patients, localized 
at tumor sites.  When these sites were irradiated with red light (~630 nm), a selective 
tumor destruction/shrinkage resulted.  This work attracted the attention of other local 
surgeons and ultimately led to the use of photodynamic therapy (PDT) worldwide.  It 
was found that PDT eradicates tumors by both direct cell killing and shutdown of the 
tumor vasculature.  This latter finding ultimately led to one of the early major successes 
in the field of PDT: the use of a photosensitizing agent for the treatment of macular 
degeneration (Dougherty, Gomer et al. 1998).  This is a common condition, leading to 
impaired vision, resulting from a proliferation of blood vessels in the eye. 
The protocol termed ‘PDT’ involves the use of three components; a 
photosensitizing agent that is harmless in the absence of light, a light source that is 
used to ‘activate’ the drug but is otherwise harmless, and dissolved molecular oxygen in 
the tissue/cells (Dougherty, Gomer et al. 1998; Agostinis, Berg et al. 2011).  The 
wavelength of light for activation must correspond to an absorbance band of the 
photosensitizer being used.  This can vary as a function of the chemical structure of the 
photosensitizing agent. The optimal wavelength for clinical efficacy is in the red or near 
infrared, since these wavelengths penetrate tissues most effectively.  Shorter 
wavelengths of light are scattered by tissues and their penetration is severely limited.  It 
has been estimated that, under ideal conditions, light in the vicinity of 650-700 nm can 
penetrate to a depth of at least one centimeter.  Absorption of a photon leads to the 
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formation of an ‘excited state’ of the photosensitizing agent.  When this energy is lost as 
the photosensitizer returns to ground state, three different effects can occur.  The 
absorbed energy can be lost as heat or released in the form of light, emitted at a longer 
wavelength (fluorescence).  The excess energy can also be transferred to another 
molecule. When this involves oxygen, there can be a charge-transfer reaction that 
initially results in formation of a series of oxygen and other radical species.  This is 
termed a ‘Type I’ reaction.  An energy-transfer (Type II) can also occur (Foote 1991).  
This results in the alteration of the spin of a single electron, resulting in formation of a 
highly reactive oxygen molecule: singlet oxygen (1O2).  Singlet oxygen can catalyze 
oxidation of any nearby biological species, often with cytotoxic consequences.  It should 
be noted that the fluorescence of the photosensitizer can also be used for tumor 
localization if an appropriate detection system is available.  
The first oxygen radical formed is most often superoxide anion (•O2-).  This 
species is converted both spontaneously and by the action of superoxide dismutase 
(SOD) to hydrogen peroxide (H2O2), a molecule with a much longer half-life than other 
reactive oxygen species (ROS).  Hydrogen peroxide can, unlike other ROS, pass 
through biological membranes and cause damage in other cellular compartments 
(Plaetzer, Krammer et al. 2009).  Hydrogen peroxide is detoxified by the enzyme 
catalase, resulting in formation of H2O + O2.  Hydrogen peroxide can also be converted 
to a highly reactive product, the hydroxyl radical (•OH), via the Fenton reaction and 
other processes.  The Fenton reaction involves the catalytic action of metal ions, e.g., 
Fe+2, but this reaction can also be mediated by certain enzymatic processes. 
Both Type I and Type II reactions can occur simultaneously, with the ratio 
between these processes depending on the photosensitizer, as well as the 
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concentrations of substrate and oxygen (Castano, Demidova et al. 2004; Plaetzer, 
Krammer et al. 2009).  Because of the high reactivity and short half-life of singlet 
oxygen and the oxygen radicals, only molecules and structures that are proximal to the 
site(s) of their production, i.e. sites of photosensitizer localization, are subject to PDT 
phototoxicity.  
Two factors promote the selectivity of PDT. For reasons not yet completely 
understood, some photosensitizing agents show affinity for tumors and their 
vasculature.  Moreover, the photosensitizers are inactive until irradiated.  This is an 
important consideration since sensitizers often partition to the liver and spleen.  Since 
these sites can be shielded from light, they are spared from toxicity.  Because of the 
high degree of specificity allowed by this therapy, adverse effects associated with 
conventional chemotherapy are absent when PDT is used.  The reactive singlet oxygen 
species has a very short half-life, restricting photodamage to a < 20 nm region from the 
site of formation (Moan and Berg 1991).  The cytotoxic effect of PDT is therefore 
confined to close proximity of the tumor site, resulting in minimal destruction of normal 
tissue upon irradiation.  Light delivery by means of lasers coupled to fiber cables 
permits selective exposure of sites to irradiation, as to also spare damage to 
surrounding normal tissue (Sibata, Colussi et al. 2000). 
In the clinical setting, PDT can be used as a single agent for treatment of cancer 
or can be combined with other antitumor treatments without the risk of inducing cross-
resistance.  PDT can also be used in combination with surgery using fluorescence-
guided illumination to eradicate malignant lesions (Allison, Downie et al. 2004).  It is 
also feasible to irradiate the tumor bed after resection to eradicate residual tumor.  PDT 
has been successfully combined with radiotherapy and chemotherapy (Sibata, Colussi 
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et al. 2000; Agostinis, Berg et al. 2011).  It has been observed that PDT can promote 
responses in malignant lesions that are resistant to drugs and ionizing radiation 
(Cuenca, Allison et al. 2004).  Drug resistance occurs when malignant cells develop 
mechanisms that allow them to survive in the presence of chemotherapy. PDT can 
bypass drug resistance pathways because phototoxicity involves triggering the late 
stages of apoptosis, avoiding defective signalling pathways often found in neoplastic 
cells.  
PDT is currently being used in the treatment of several types of cancers including 
basal cell carcinomas, early carcinomas of the oral cavity, pharynx, larynx, and 
esophagus preserving normal tissue and vital functions of speech and swallowing.  
Cancers of the GI, lung, bladder, and brain have also been successfully treated with 
PDT (Agostinis, Berg et al. 2011).  In the treatment of cancer patients, PDT holds 
several advantages over the three primary modes of cancer therapy used today 
(surgery, chemotherapy, and radiation); a) in being minimally invasive and requiring 
only illumination of the tumor tissue, the treatment of irresectable tumors is possible. b) 
PDT can be repeated without detrimental consequences to the patient; c) the therapy 
does not result in systemic immunosuppressive effects which can lead to possible 
infections (Robertson, Evans et al. 2009). An obvious consideration is that the site(s) of 
neoplasia need to be known so that light can be directed to the appropriate sites. 
Several explanations have been suggested for the preferential binding of 
sensitizers to neoplastic tissues: low tumor pH, elevated LDL (low density lipoprotein) 
receptor expression, poorly developed lymphatic drainage, and abnormal tumor 
neovascularization.  Some photosensitizers are known to bind to LDL and are thereby 
directed to malignant cells that often express high levels of LDL receptors.  There are, 
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however, sensitizers that bind high-density lipoproteins, e.g., NPe6 (mono-L-aspartyl 
chlorin e6), and LuTex (lutetium texaphyrin), so there appear to be multiple 
determinants of localization (Hamblin and Newman 1994; Dougherty, Gomer et al. 
1998; Castano, Demidova et al. 2005).  
Many porphyrin molecules and analogs have been identified that can induce 
photodynamic cell death.  Photosensitizers can localize in mitochondria, ER 
(endoplasmic reticulum), lysosomes, plasma membrane and even the nucleus 
(Castano, Demidova et al. 2004).  One group of effective photosensitizers, represented 
by CPO [9-capronyloxy-tetrakis(methoxyethyl) porphycene] and mTHPC [meta- 
(tetrahydroxyphenyl)chlorin], localize at the ER and catalyze photodamage to the anti-
apoptotic molecule Bcl-2, leading to a rapid apoptotic response.  Oleinick's group 
reported that the photosensitizer phthalocyanine 4 (Pc4), a mitochondrial 
photosensitizer, also causes Bcl-2 photodamage (Xue, Chiu et al. 2001).  The tin 
etiopurpurin (SnET2) localizes in both the mitochondria and lysosomes (Kessel, Luo et 
al. 1997), but the predominant effect of the sensitizer appears to be on Bcl-2.  Effects 
associated with Bcl-2 photodamage include loss of protection by this anti-apoptotic 
protein.  This leads to a decreased mitochondrial membrane potential, increased 
mitochondrial membrane permeability and cytochrome c release.  The appearance of 
cytochrome c in the cytoplasm is a trigger for the irreversible process of apoptosis, 
initiated by caspase-3 activation. 
Another group of photosensitizers, represented by the chlorin NPe6, LuTex, and 
the bacteriochlorin analog WST11, targets lysosomes.  Other photosensitizing agents 
localize in the plasma membrane where irradiation leads to necrosis via membrane 
photodamage (Dougherty, Gomer et al. 1998; Allison, Downie et al. 2004).  The cationic 
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porphyrin, 5,10,15,20-tetrakis (N-methyl-4-pyridyl)-21H,23H porphyrin (TMPyP) has an 
unusual mode of photodynamic action; it localizes to the nuclei and irradiation leads to 
damage to guanine residues in DNA, triggering apoptosis (Tada-Oikawa, Oikawa et al. 
2009).  
1.1.1 Apoptosis  
Apoptosis is an important process for maintaining a balance between growth and 
death, and in embryonic development.  In malignant cells, apoptosis is often 
suppressed or defective, allowing uncontrolled cell proliferation.  Apoptosis has been 
described as a system of ‘programmed cell death’ that can involve extrinsic or intrinsic 
pathways.  Both pathways involve the mitochondrion and several membrane-bound and 
cytosolic proteins.  The program is mediated by a cascade of events that ultimately 
leads to irreversible caspase activation and cell fragmentation.  Caspases are cysteine 
proteases that are inactive until activated by apoptotic signal (Nunez, Benedict et al. 
1998).  The caspases are characterized as initiators (caspases-8 and -9) or 
executioners (caspases-3, -6, -7) (Grutter 2000).  Activation of initiator caspases leads 
to executioner caspase activation and irreversible cell death.  Typical morphological 
characteristics of apoptosis are DNA fragmentation into endonucleosomes, cell 
shrinkage, membrane blebbing, intact organelles and formation of apoptotic bodies.  
The anti-apoptotic proteins Bcl-2 and Bcl-xL are targets for some photosensitizing 
agents, i.e., when mitochondria or the ER are PDT targets (Kim, Luo et al. 1999; Xue, 
Chiu et al. 2001).  The loss of Bcl-2 will almost invariably trigger an apoptotic response. 
A second mechanism for the photodynamic triggering of apoptosis involves the 
release of proteases from photodamaged lysosomes.  These enzymes can cleave the 
pro-apoptotic protein Bid to form a truncated form (t-Bid) that can directly interact with 
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mitochondria and promote release of cytochrome c and the initiation of apoptosis 
(Reiners, Caruso et al. 2002). 
1.1.2 Necrosis 
Necrosis can occur when the degree of photodamage is so great that enzymes 
needed for the apoptotic process are destroyed.  Such a high dose of light and/or drug 
will generally lead to loss of PDT selectivity since a low concentration of 
photosensitizers is often found in normal tissues (He and Oleinick 1995; Luo and Kessel 
1997).  Moreover, necrosis can lead to the release of tumor DNA into the circulation–a 
process with possibly adverse consequences.  
1.1.3 Autophagy 
Photodamage can also lead to the initiation of autophagy.  This process involves 
the formation of vacuoles (autophagosomes) that engulf cellular components 
(intracellular proteins and organelles).  This is most often associated with starvation 
conditions where cells recycle a portion of their components to remain viable.  The 
process concludes with the fusion of the outer membranes of autophagosomes and with 
lysosomes.  Hydrolases and lipases in the lysosomal lumen then degrade the 
autophagic contents, with the resulting amino acids, fatty acids, and nucleosides 
released back into the cytosol for reutilization by the cell (Levine and Klionsky 2004; 
Gozuacik and Kimchi 2007; Yang and Klionsky 2009; Wirawan, Vanden Berghe et al. 
2012).  While autophagy is usually considered as a pro-survival mechanism, if 
autophagy becomes excessive, it may lead (or be associated with) to cell death (Kessel 
and Oleinick 2009).  It is not yet clear whether autophagy is actually a death 
mechanism.  Some authors prefer to use the term ‘death with autophagy’ (Kroemer and 
Levine 2008), suggesting that death arises by other mechanisms that can also evoke an 
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autophagic response.  It is important to consider that Bcl-2 is also an anti-autophagic 
protein.  It forms a complex with the pro-autophagic protein Beclin-1.  Any process 
leading to the loss Bcl-2 could therefore trigger autophagy (Pattingre and Levine 2006).  
1.1.4 Induction of cell death by PDT  
A mechanism for PDT-induced cell death can therefore be proposed.  
Photodamage to Bcl-2 or activation of Bid leads to initiation of apoptosis and cell death. 
Evidence that autophagy can offer protection from PDT has been provided by Oleinick’s 
group (Xue, Chiu et al. 2008) and by the finding that inhibition of autophagy promotes 
PDT efficacy.  When autophagy was limited by a knockdown of a critical autophagy 
gene (Atg7), the ‘shoulder' on the dose response curve was lost, indicating a role of 
autophagy in promoting survival at low PDT doses (Andrzejak, Price et al. 2011).  In a 
recent study, it was shown that the photosensitizer BPD could inhibit autophagy at high 
concentrations in the dark (Donohue, Tovey et al. 2011).  When conditions were 
modified so that there was a higher drug dose and a correspondingly lower light dose, 
the result was also the loss of this ‘shoulder’, again demonstrating the ability of 
autophagy to offer some protection from photokilling (Andrzejak, Price et al. 2011).  This 
result also suggested a potential for use of high-dose BPD as a means of promoting 
PDT efficacy, with the light-dose appropriately reduced. 
1.2 HYPOTHESIS 
With the possibility that both Type I and II reactions can occur in parallel, the 
particular reactive oxygen species being formed during the irradiation process can be 
an important determinant of PDT efficacy. Having a better understanding of the 
pathways of ROS formation can therefore aid in analyzing PDT mechanisms. This can 
be accomplished through the use of agents that inhibit or facilitate ROS formation 
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(Figure 1.1).  These data are important due to the distinct properties of each ROS, 
including lifetime, diffusion distance and reactivity. Effects of the level of oxygenation 
were examined on efficacy of two agents that form different ROS upon irradiation.  The 
results indicate that PDT efficacy can be affected by the nature and persistence of ROS 
formed when the excited state of a photosensitizer interacts with dissolved oxygen.  
 
Figure 1.1 Diagram of Type I and II ROS formation during PDT. ROS formation and/or 
persistence can be altered at several points.  
1.3 AIMS  
1.3.1 ROS generated by PDT 
Many commercially available fluorescent probes are advertised to be specific for 
the detection of singlet oxygen, superoxide, hydrogen peroxide or other ROS. 
Specificity of these probes was assessed in experiments involving the different ROS 
that can be generated during PDT.  Effects of peroxidase activity were also examined 
since this is a common cellular enzyme that can affect ROS formation.  During the 
course of these experiments, a new probe, termed DADB, was reported to be both cell-
permeable and specific for singlet oxygen (Oliveira, Severino et al. 2011).  Experiments 
were carried out to evaluate the potential utility of DADB. 
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1.3.2 A potential role for different ROS in cell death 
Singlet oxygen and •OH are sufficiently reactive so that they are expected to 
oxidize biologic molecules only at the site of formation.  Superoxide radical is also likely 
to be in this class.  Hydrogen peroxide, though less reactive, can persist for a much 
longer time in cells and tissues.  Since H2O2 can be converted to •OH, inhibition of 
catalase activity was considered to be a possible means for promotion of PDT efficacy, 
e.g., by potentiating opportunities for •OH formation.  Experiments were designed to 
evaluate effects of [a] inhibition of catalase activity, and [b] use of an exogenous source 
of catalase.  
1.3.3 Role of oxygenation on PDT efficacy 
Tumor hypoxia has proven to be a cause of radiation and chemotherapy 
resistance. Since oxygen is one of the primary components of PDT, experiments were 
designed to evaluate the effects of decreasing oxygen levels on the efficacy and 
photochemical properties of two photosensitizers.  As previously mentioned, the 
photosensitizer NPe6 produces mainly singlet oxygen upon irradiation and localizes in 
lysosomes.  It was later discovered that the photosensitizer termed WST11 also 
localized in lysosomes (Kessel, Price et al. 2012), but produces only oxygen radicals 
upon irradiation in an aqueous environment (Ashur, Goldschmidt et al. 2009).  This 
provided us with an opportunity to compare two photosensitizers with the same cellular 
localization pattern but with markedly different patterns of ROS formation.  
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CHAPTER 2 
USE OF FLUORESCENT PROBES FOR DETECTING ROS AND RNS  
2.1 INTRODUCTION  
The literature contains numerous reports on the use of fluorescent probes for 
detection of ROS and reactive nitrogen species (RNS).  Invitrogen/Molecular Probes 
provides a collection of such probes for which the only indication of specificity is 
provided by the reproduction of a table derived from Setsukinai, Urano et al. (2003).  
This table compared the fluorescence of two new fluorescein analogs, 3’(p-
aminophenyl) fluorescein (APF) and 3’(p-hydroxyphenyl) fluorescein (HPF), with the 
fluorescence of 2’,7’-dichlorofluorescein (DCF) in a cell-free system containing 
chemicals that generate different ROS.  Experiments were designed to characterize the 
specificity of some common fluorescent probes.  
2.2 MATERIALS AND METHODS 
2.2.1 Chemicals and Reagents 
Several fluorescent probes including 4’,5’-diaminofluorescein (DAF), 
dihydroethidine (DHE), reduced DCF (H2DCF-DA) and dihydrorhodamine (DHR), were 
obtained from Invitrogen/Molecular Probes, Eugene, Oregon. H2DCF was prepared 
from the commercially available diacetete by alkaline hydrolysis as described by Doshi, 
Tian et al. (2007).  Diethylamine nitric oxide (DEANO) was provided by the Cayman 
Chemical Co., Ann Arbor, Michigan. ROS examined were •O2− [100 µM KO2 in 
anhydrous dimethyl sulfoxide (DMSO)], H2O2 (100 µM), and •OH [formed from 20 µM 
Fe(NH4)SO4 +100 µM H2O2].  Fluorogenic effects of reactive nitrogen species were 
estimated using DEANO (100 µM). In aqueous media, NO is released from this 
compound at pH 7.  NO is then spontaneously oxidized to the nitrosonium cation. 
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Horseradish peroxidise (HRP) was purchased from Sigma-Aldrich (St. Louis, MO).  The 
Bcl-2 antagonist HA14-1 was purchased from Ryan Scientific Inc. (Isle of Palms, SC). 
Benzoporphyrin derivative (Verteporfin, BPD) was purchased from VWR.  Stock 
solutions (10 mM) were prepared in dimethylformamide and stored at 4°C in the dark.  
2.2.2 Statistical analyses 
Paired one-tailed t-tests were carried out between each group of fluorescent data 
(± HRP) collected for each probe (Graphpad Software, San Diego, CA).  Differences 
between data sets were scored as statistically significant if p < 0.05. 
2.2.3 Cell culture  
Murine leukemia P388 cells were grown in sealed flasks, using an approximation 
of Fisher’s Medium consisting of αMEM (Sigma-Aldrich, St. Louis, MO) supplemented 
with MgCl2 (45 mg/L), methionine (75 mg/L), phenylalanine (30 mg/L), valine (30 mg/L), 
folic acid (9 mg/L), 1 mM glutamine, 1 mM mercaptoethanol, gentamicin, and 10% 
horse serum. Cells were maintained in suspension culture at 37°C in a 5% CO2 
atmosphere. 
2.2.4 Measuring probe fluorescence 
Tests were carried out using 5 µM concentrations of each probe in 3 ml of 
HEPES buffer pH 7.0.  Fluorescence was measured 30 min after addition of the 
reagents specified above.  Fluorescence excitation was provided by a 100-W quartz-
halogen lamp with the wavelength selected by a monochromator.  Fluorescence 
emission was monitored using an Instaspec IV (Oriel Corp, Stratford, Connecticut) CCD 
system.  Excitation/emission optima were 485 nm/515 nm (DAF), 500 nm/520 nm 
(DCF), 500 nm/570 nm (DHE), 490 nm/530 nm (DHR), and 490 nm/515 nm (APF). 
Fluorescence intensity at the emission optimum was recorded. Horseradish peroxidase 
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(50 µg/ml) was present where specified. In studies involving DHE, DNA (50 µg/ml) was 
added since the formation of a long-wavelength fluorescence signal depends on binding 
of the oxidation product(s) to DNA. 
All fluorescence measurements are indicated in terms of ‘dimensionless’ units.  
These cannot be compared between instruments (fluorescence microscopy, CCD multi-
channel signal detection, SLM (steady-state single point fluorescence measurements)). 
Data obtained from single instruments can, however, be compared.  
2.2.5 ROS formation in cell culture 
To examine the effects of an RNS detector in vitro, P388 cell suspensions were 
incubated for 60 min at 37°C with 2 µM BPD + a 5 µM concentration of the RNS probe 
DAF (added during the final 30 min).  The cells were then collected by centrifugation 
(100 g, 30 s), washed, resuspended in fresh medium at 15°C and irradiated.  The light 
source was a 600 W quartz-halogen lamp with infrared radiation attenuated by a 10 cm 
layer of water and limited to 690 ± 10 nm by an interference filter (Oriel, Stratford, CT).  
2.2.6 Fluorescence microscopy 
After irradiation, cells were collected by centrifugation and examined by 
fluorescence microscopy. Images were acquired with a Photometrics CoolSnap HQ 
CCD camera operating at −40°C.  
2.3 RESULTS AND DISCUSSION 
2.3.1 Fluorogenic reactions of ROS probes 
Reactions resulting from exposure of five fluorogenic probes to reactive oxygen 
and nitrogen species were examined in a cell-free system, following procedures 
reported in Setsukinai, Urano et al. (2003), with minor variations. Results are 
summarized in Table 2.1.  The fluorogenic response by DCF was elicited by •OH >> 
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H2O2 > •O2−, with enhanced promotion when peroxidase was present. DHE and DHR 
also responded to these ROS, but no substantial degree of selectivity for any ROS was 
observed.  It has been reported that DHE can be selective for •O2− detection if 
fluorescence (in the presence of DNA) is monitored at 570 nm (Zhao, Kalivendi et al. 
2003), but this probe cannot be used for an unambiguous detection of superoxide 
without an HPLC analysis of products (Zielonka and Kalyanaraman 2010).  
The presence of HRP led to a strong promotion of probe fluorescence. HRP can 
promote probe oxidation by a variety of mechanisms including by direct interactions and 
via conversion of H2O2 to •OH (Kohler and Jenzer 1989; Gorris and Walt 2009).  While 
APF was selective for •OH, especially in the presence of HRP, (Price, Reiners et al. 
2009) this probe can also detect 1O2 to a somewhat greater extent than was suggested 
by Setsukinai, Urano et al. (2003) in the context of PDT.  DAF was converted to a 
fluorescent product by NO > •OH >> H2O2 and •O2−; there was also an increase in 
fluorescence when HRP was present.  It has been reported by Setsukinai, Urano et al. 
(2003) that APF can readily detect peroxynitrite ion (ONOO−).  The lack of response of 
APF to NO shown in Table 2.1 indicates that this species is not being produced during 
release of NO from the diethylamine derivative. 
Table 2.1 Probe:ROS interactions  
  H2O2  •OH  •O2-  NO 
Probe  -HRP +HRP  -HRP +HRP  -HRP +HRP  -HRP +HRP 
DHE  170 1882  3802* 3906*  1372 4241  104 124 
DHR  424 6474  3571 12327  51 504  1776§ 1726§ 
H2DCF  775 2768  10122 23966  427 1806  739 4115 
APF  260 1030  5960 6945  42 62  51 210 
DAF  226 3288  805 7375  104 1422  2430 5434 
Fluorogenic interactions between selected fluorescence probes (5 µM) and reactive oxygen or nitrogen 
species generated as defined in the text. Numbers represent mean fluorescence emission intensity upon 
excitation at 490 - 510 nm. Baseline values were subtracted from all determinations. In four replicate 
determinations, the variation was less than ± 3% of the values shown. The symbols * and § indicate pairs 
that were not significantly different. [Adapted from the J. Biomed. Opt. 15, 051605, 2010]  
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2.3.2 HA14-1 and ROS production in cell culture 
During a preliminary study, a situation was encountered where a fluorogenic 
effect involving an ROS probe did not actually detect an ROS.  Such interactions really 
involve only a conversion of a non-fluorescent structure to one that can fluoresce, often 
as a result of an interaction with an electron donor.  The Bcl-2 antagonist HA14-1 was 
shown to promote the apoptotic response to PDT (Kessel 2008).  When a report (Doshi, 
Tian et al. 2007) appeared indicating that HA14-1 could cause the spontaneous 
production of ROS, this was considered to be highly unlikely.  The ability of HA14-1 to 
evoke formation of ROS was based on studies involving reduced dichlorofluorescein 
(H2DCF).  The fluorescence observed when HA14-1 was added to cell cultures was 
actually derived from a fluorogenic reaction between HA14-1 and serum albumin that 
exactly mimicked the excitation and emission properties of the oxidized product DCF 
(Kessel, Price et al. 2008).  
2.3.3 Artefacts in the Study of Fluorogenic Interactions 
Another potential problem associated with use of fluorescent probes in the 
context of PDT is illustrated by Figure 2.1.  Murine leukemia P388 cells were 
photosensitized as described in section 2.2.5 and irradiated at 690 nm (90 mJ cm-2), 
conditions that kill 50% of the cell population.  Fluorescence microscopy was then used 
to assess the resulting fluorogenic interactions using 450–490 nm excitation and 
monitoring fluorescence at 500–550 or 500–700 nm.  Experimental conditions included 
probe alone [Figure 2.1(a–c)], probe + photosensitizer in the dark [Figure 2.1(d–f)], and 
after irradiation [Figure 2.1(g–i)].  
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Figure 2.1 Phase contrast and fluorescence images of murine leukemia P388 cells 
incubated with BPD + DAF and irradiated as described in the text: (a) to (c) control cells 
containing only DAF, (d) to (f) cells containing DAF + BPD but not irradiated, and (g) to 
(i) irradiated cells loaded with DAF + BPD. Images (a), (d), and (g) represent phase 
contrast images; (b), (e), and (h) are fluorescence images acquired at 500–700 nm 
(BPD and DAF fluorescence) for 100 ms; and (c), (f), and (i) are fluorescence at 500–
550 nm acquired for 2000 ms (DAF fluorescence only). Photographs are representative 
of observations for three independent experiments. [Adapted from the J. Biomed. Opt. 
15, 051605, 2010] 
Images obtained with broadband (500–700 nm) acquisition indicated a 
substantial fluorogenic response when BPD was present, but this occurred whether or 
not the photosensitized cells were irradiated [compare 2.1(e) and (h)].  The 
fluorescence signal was associated with mitochondria, the site where BPD is localized 
(Peng, Chang et al. 2005).  These results remind us that photosensitizing agents also 
fluoresce, so that care must be taken to exclude their fluorescence from the probe 
detection.  Fluorescence images obtained with narrowband fluorescence acquisition 
[Figure 2.1(c, f, and i)] revealed the lack of a fluorogenic response to DAF, indicating the 
18 
 
absence of RNS formation upon irradiation. In contrast, broadband fluorescence images 
do show enhanced fluorescence, but from BPD.  The relative intensities of the 
fluorescence of BPD vs. DAF can be appreciated by noting the time needed for image 
acquisition: 100 ms for Figure 2.1(b, e, and h) and 2000 ms for Figure 2.1(c, f, and i). 
These experiments illustrate potential problems that can occur in studies 
involving the use of fluorescent probes.  There may be fluorogenic interactions not 
associated with ROS, or confusion between the fluorescence of the probe(s) and of the 
photosensitizer. In studies reported here, care was taken to eliminate such artefacts.  
2.4 CONCLUSIONS 
Based on studies in cell-free systems, together with additional experiments that 
will be reported elsewhere in this document, it appears that DHR can be used to 
distinguish H2O2 from •O2−, but that peroxidase activity or presence of •OH can 
complicate interpretation of results.  A prior report arrived at a similar conclusion 
(Henderson and Chappell 1993).  DHE is indeed more responsive to •O2− than to H2O2, 
but can be oxidized by other ROS (Zielonka and Kalyanaraman 2010).  Of the five 
probes tested, APF was the only product that was highly selective for a single ROS: 
•OH, and could therefore be responsive to hydrogen peroxide in the presence of 
peroxidase activity.  The pathway to fluorogenic interactions with the probes in the 
presence of peroxidase activity is not a simple one.  The mechanism has been explored 
by Kobayashi, Nakano et al. (1987).  The important point is that variable levels of 
cellular peroxidase activity can affect the results obtained with many fluorescent probes 
for ROS. 
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CHAPTER 3  
MONITORING 1O2 AND •OH FORMATION  
3.1 INTRODUCTION 
The contributions of the various ROS types generated during PDT to the 
biochemical and morphological changes after PDT are often inferred by the inclusion of 
ROS type-specific scavengers.  What is missing are simple fluorescence-based assays 
for real-time monitoring of specific types of ROS. 
APF and HPF, were synthesized by Setsukinai, Urano et al. (2003) as probes for 
stable and selective detection of •OH.  Both probes were reported to be cell-permeable, 
relatively insensitive to •O2−, nitric oxide, and alkyl peroxides and free from the auto-
oxidation associated with some other probes.  There was some reported 
responsiveness to 1O2, but only at 0.5% of the level found for •OH.  The two probes 
differed in their responsiveness to hypochlorite ion (ClO−).  APF was converted to a 
fluorescent form by ClO− while HPF was not. HPF and APF were examined as cell-
permeable probes for the detection of •OH during PDT.  
A fluorogenic probe for detection of singlet oxygen described by Flors, Fryer et 
al. (2006) was also examined.  Several relatively specific quenching agents were also 
employed: these included sodium azide (NaN3) for 1O2, and DMSO for •OH (Wasil, 
Halliwell et al. 1987; Wei, Cai et al. 1997). 
3.2 MATERIALS AND METHODS 
3.2.1 Chemicals and Reagents 
For generation of 1O2, TPPS was employed (Porphyrin Products, Logan, UT). 
Solutions (10 mM) were made up in water and stored at 4°C in the dark.  Structures of 
APF and HPF are shown in Figure 3.1.  Singlet oxygen sensor green (SOSG) was 
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purchased from Invitrogen/Molecular Probes, Eugene, Oregon. Refer to section 2.2.1 
for details on other chemicals used in this study. 
 
Figure 3.1 Structures of HPF and APF and the oxidative reaction that leads to the 
formation of fluorescein. [Adapted from Photochem. Photobiol. 85, 1177-81, 2009] 
3.2.2 Fluorescence assay procedure 
An SLM 48000 fluorometer, modified by ISS (Champaign, IL), was used for 
acquisition of fluorescence signals as a function of time.  When APF or HPF was 
employed, fluorescence emission at 525 nm was measured upon excitation at 492 nm 
using 2 nm slit widths for both excitation and emission. With SOSG, the corresponding 
values were 505 and 525 nm, respectively. 
Studies involving a cell-free system were carried out in 1 × 1 × 3 cm glass 
cuvettes maintained at a temperature of 20°C by a Peltier system, and stirred 
constantly.  When diode lasers were used for irradiation, the influence of stray light from 
the laser was minimized by insertion of a 500 ± 25 nm interference filter into the 
emission beam. In all such experiments, the fluorescent probes were present at 3 µM 
concentrations. 
21 
 
3.2.3 Singlet oxygen formation 
Singlet oxygen was generated by a photodynamic reaction in 3 mL of 100 mM 
phosphate buffer pH 7.0, H2O or deuterium oxide (D2O), along with 10 µM TPPS.  A 
400 µM fiber bundle was used to transfer 649 nm light from a laser diode to the top 
surface of the cuvette, using a power density of 1 mW cm-2.  This permitted the 
acquisition of a fluorescence signal in real time.  Data points were acquired at 4 s 
intervals over 180 s.  The increase in probe fluorescence as a function of time was 
found to be linear for at least 120 s.  Data were collected using Vinci software and the 
fluorescence intensity values after 120 s were used for analyses. 
3.2.4 Formation of hydroxyl radical 
This ROS was generated by the Fenton reaction using an initial mixture 
containing 100 mM phosphate buffer pH 7.0, 0.3 mM Fe(NH4)2(SO4)2, (FAS).  Addition 
of 0.3 mM H2O2 resulted in a rapid increase in fluorescence.  Data shown represent the 
steady-state fluorescence signal minus the base-line signal obtained before addition of 
H2O2 (Table 3.1).  In  the data  reported  and  published  in Table 3.1,  the  fluorogenic  
Table 3.1 Fluorogenic response to •OH in a cell-free system 
 Fluorescence Units 
System APF HPF 
H2O2 0  
FAS + H2O2 6117 ± 420 1339 ± 75 
FAS + H2O2 + 1% DMSO 170 ± 18* 37 ± 11† 
FAS + H2O2 + 0.1% DMSO 680 ± 35* 148 ± 36† 
FAS + H2O2 + 0.02% DMSO 2980 ± 806* 630 ± 25† 
Cuvettes contained 3 mL of 100 mM phosphate buffer (pH 7.0), 3 µM APF or HPF and 300 µM FAS plus, 
where specified, DMSO. After a stable base-line was established (excitation = 492 nm, emission = 525 
nm), H2O2 was added (300 µM) and the increase in fluorescence was monitored over 120 s, by which 
time there was no further increase. Data represent the mean ± SD for three determinations (n=3), and 
represent fluorescence (in arbitrary units) above the base-line level. The symbols * and † represent values 
that are significantly different from readings obtained with FAS + H2O2 (p < 0.05). We could not detect a 
fluorogenic response to hydrogen peroxide alone. [Adapted from Photochem. Photobiol. 85, 1177-81, 
2009] 
interaction in a sample containing H2O2 alone was not evaluated since Setsukinai, 
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Urano et al. (2003) had reported that this ROS was approximately 0.1% as effective as 
OH• in inducing APF fluorescence.  In a separate study carried out after this table was 
published, this was confirmed. Using a CCD detection system, we found that the 
fluorogenic interaction between H2O2 and APF negligible; 300 µM H2O2 had no effect on 
the baseline fluorescence intensity of 3 µM APF. An additional 300 µM H2O2 added in 
100 µM increments had no further effect on APF fluorescence. 
3.2.5 Quenching studies 
Fluorogenic interactions involving 1O2 and •OH and fluorescent probes were 
assessed in the absence vs. presence of inhibitors (NaN3 or DMSO) using SOSG, APF 
or HPF in systems described above.  Data are reported in Figure 3.2 and Figure 3.3 and 
in Table 3.1.  
3.2.6 Cell culture 
Cell culture maintenance for L1210 murine leukemia is the same as described in 
section 2.2.3. 
3.2.7 Photodynamic studies in cell culture 
L1210 cell suspensions were incubated for 30 min at 37°C with 2 µM BPD + 3 
µM APF.  See section 2.2.5 for a description of the procedure. In replicate tubes DMSO 
(1%), 100 µM desferroxamine (DFO) or both reagents were added.  The light dose was 
67.5 mJ cm−2 at 690 ± 5 nm, as determined with a ScienTech H10T radiometer.  This 
PDT dose was found to reduce cell viability to 11 ± 3% of control values, as indicated in 
prior studies involving clonogenic assays.  
3.2.8 Fluorescence microscopy 
After irradiation, cells were collected by centrifugation and examined by 
fluorescence microscopy using 450–490 nm excitation, monitoring emission at 520–600 
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nm.  The images were acquired by a Photometrics CoolSnap HQ CCD camera 
operated at −40°C.  An exposure time of 1000 ms was required to obtain the images 
shown in Figure 3.4.  A B2A filter cube was used (excitation = 450–490 nm).  The 
emission was controlled by a high-pass 520 nm filter and an additional 600 nm low-pass 
filter to screen out fluorescence derived from BPD.  Images of cellular fluorescence 
were captured using MetaMorph software (Molecular Devices, MDS Analytical 
Technologies).  Average pixel intensities were determined using ‘region statistics’ 
procedure.  
3.2.9 Region statistics analysis procedure 
A ‘thresholding’ process was used to select only those portions of the image 
representing cellular fluorescence.  The black pixels in the background were gated (not 
counted) and omitted from the calculations.  Any extremely bright pixels were also gated 
and an average grayscale analysis was then calculated as the summation of the values 
for each pixel contained in the images of the cells (0 = black, 255 = white).  This value 
was then divided by the total number of pixels to provide an average pixel brightness.  
3.2.10 Statistical analyses 
Data for fluorescent probes were analyzed by using paired one-tailed t-tests.  
Differences between data sets were scored as statistically significant if p < 0.05. 
Statistical analyses of ‘region statistics’ data was done using unpaired one-tailed t-tests, 
using the number of cells in the field as the sample size, n.  Differences between data 
sets were scored as statistically significant if p < 0.05.  
3.3 RESULTS AND DISCUSSION 
3.3.1 Fluorogenic response of HPF and APF to •OH and quenchers 
The effects of •OH on APF and HPF fluorescence are summarized in Table 3.1.  
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APF yielded ~5-fold more fluorescence during •OH formation than did HPF. Setsukinai, 
Urano et al. (2003) reported that APF was more sensitive than HPF to oxidation by •OH 
by a factor of 1.7.  In experiments reported here, FAS replaced the salt Fe(ClO4)2 
employed by Setsukinai, Urano et al. (2003).  Use of the latter resulted in formation of a 
precipitate in phosphate buffer. There was no precipitation when FAS was used as the 
source of ferrous iron. 
In a cell-free system, the fluorogenic reaction of •OH with HPF or APF was 
quenched ~50% by 0.02% DMSO (vol / vol).  A concentration of 0.1% DMSO, often said 
to be safe for use in biological studies, was found to decrease the fluorogenic response 
of APF to •OH by >90% (Table 3.1).  For both APF and HPF, additions of DMSO at all 
concentrations led to significant decreases in fluorescence intensities from the baseline 
reading with FAS + H2O2.  
3.3.2 Determinants of singlet oxygen formation 
Singlet oxygen formation was monitored with the probe SOSG (Figure 3.2, top).  
During irradiation of an aqueous solution of TPPS + SOSG, there was an increase in 
525 nm fluorescence that was markedly enhanced when D2O was substituted for water.  
This effect is to be expected since the lifetime of the triplet state is strongly promoted in 
deuterated solvents (Moan and Wold 1979; Gorman and Rogers 1989).  The 
fluorogenic effect of 1O2 on SOSG was very slightly enhanced by the presence of 100 
mM phosphate buffer pH 7.0, compared with water alone. 
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Figure 3.2 Monitoring singlet 
oxygen formation with SOSG. 
Top: fluorogenic interaction 
between 3 µM SOSG and 1O2 
during the irradiation (649 nm) in 
10 µM TPPS. Solvents were 
D2O, 100 mM sodium phosphate 
buffer pH 7.0, or water, using a 
light flux of 1 mW cm−2. 
Fluorescence was monitored 
using excitation = 505 nm, 
emission = 525 nm. Bottom: 
fluorescence quenching during 
irradiation of SOSG + TPPS in 
phosphate buffer by 1 or 10 mM 
NaN3 and by 1% DMSO. Similar 
results were obtained with an 
additional two replicate 
experiments. [Adapted from 
Photochem. Photobiol. 85, 1177-
81, 2009] 
 
 
 
 
 
 Quenching studies carried out with SOSG in phosphate buffer (Figure 3.2, 
bottom) showed only a minor effect of 1% (vol / vol) DMSO on 1O2-mediated 
fluorescence, but a substantial quenching of the fluorogenic reaction by NaN3. 
3.3.3 Fluorogenic responses of HPF and APF to singlet oxygen 
Irradiation of an aqueous solution containing APF + TPPS resulted in a 
fluorogenic response that was enhanced >25-fold in D2O (Figure 3.3).  This fluorogenic 
reaction was also slightly greater in phosphate buffer than in water.  Additional studies 
(in phosphate buffer)  revealed  only  a  slight  quenching  of  APF fluorescence  by 1%  
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Figure 3.3	  Fluorogenic responses of APF and HPF to singlet oxygen using 10 µM TPPS 
+ APF in D2O, phosphate buffer or water during irradiation (649 nm). Also shown are 
effects of 1 mM NaN3 and 1% DMSO in phosphate buffer. For comparison, the 
fluorogenic reaction with HPF in D2O is also shown. Inset: the fluorogenic effect during 
irradiation of TPPS + APF during 180 s in D2O. For all studies, excitation = 492 nm, 
emission = 525 nm. Similar results were obtained with an additional two replicate 
experiments. [Adapted from Photochem. Photobiol. 85, 1177-81, 2009]  
DMSO, but a very substantial decrease by 1 mM NaN3 (Figure 3.3).  These 
characteristics are consistent with the behaviour of 1O2 + SOSG shown in Figure 3.2. 
HPF was substantially less sensitive to a fluorogenic reaction with 1O2 than was 
APF.  In D2O, the production of fluorescence upon the interaction of 1O2 with APF during 
irradiation proceeded at a ~35-fold greater rate than with HPF (Figure 3.3, line 
designated “HPF D2O”).  These values differ from what was reported in Setsukinai, 
Urano et al. (2003), where HPF was found to be ~50% as responsive to 1O2 as APF.  In 
Setsukinai, Urano et al. (2003), the comparison was also carried out in phosphate 
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buffer.  Deuterium oxide was used to increase the signal-to-noise ratio since the 
fluorogenic interaction between HPF and 1O2 in H2O or phosphate buffer was barely 
detectable (not shown).  Since DMSO is known to quench •OH but not 1O2 (Wasil, 
Halliwell et al. 1987; Wei, Cai et al. 1997), these data show that both APF and HPF can 
detect 1O2 formed during PDT. 
It was concluded that APF can detect the high concentration of singlet oxygen 
formed during PDT involving this photosensitizing agent, even though APF is relatively 
insensitive to singlet oxygen.  In later studies, a much more sensitive singlet oxygen 
probe was employed: DADB. 
3.3.4 ROS detection in cell culture 
TPPS was useful for studies in an aqueous cell-free system since it does not 
aggregate in aqueous solution.  Aggregation can result in a significant reduction in ROS 
formation upon irradiation.  In order to carry out studies in cell culture, a more 
hydrophobic agent was used: BPD.  This photosensitizer was much more readily 
accumulated by L1210 cells.  To determine the potential usefulness of APF in PDT 
studies, we incubated L1210 cells with APF and BPD, followed by irradiation to achieve 
an LD90 PDT dose.  Fluorescence images (Figure 3.4) were obtained at the same 
camera settings.  A 600 nm low-pass filter was placed in the emission pathway to 
eliminate fluorescence derived from the photosensitizing agent.  In non-irradiated 
cultures, only a weak APF fluorescence could be detected (Figure 3.4, panel A). 
 Irradiation of photosensitized cells resulted in substantial fluorescence derived 
from APF (Figure 3.4, panel B).  Addition of 1% DMSO or the iron-chelator DFO 
resulted in a decrease in this fluorescence (Figure 3.4, panels C and D).  Adding both 
reagents simultaneously did not significantly increase this quenching (Figure 3.4, panel 
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E).  A ‘region statistics’ analysis is summarized in Table 3.2.  Images were subjected to 
a ‘threshold’ analysis where the black pixels were gated (not counted).  Any extremely 
bright pixels were also eliminated and an analyses of the average pixel brightness is 
then produced.  
 
Figure 3.4 Fluorescence images of APF fluorescence using L1210 cells 
photosensitized by BPD. A = dark control (no irradiation), B–E = irradiated cells, B = no 
additions, C = 1% DMSO, D = 100 µM DFO, E = 1% DMSO + 100 µM DFO, F = 0.1% 
DMSO. Inhibitors were present during BPD loading, and added to the culture medium 
during irradiation. Photographs are representative of observations for three independent 
experiments. [Adapted from Photochem. Photobiol. 85, 1177-81, 2009]  
Table 3.2 Region statistics analysis 
Conditions  Average grayscale value 
Control  3.8 ± 4.4 
BPD  58.5 ± 16.35 
BPD + 1% DMSO  32.8 ± 10.3* 
BPD + 100 µM DFO  32.45 ± 5.8* 
BPD + both  28.7 ± 14.5* 
BPD + 0.1% DMSO  49 ± 12.7 
These numbers represent the pixel brightness analyses (mean ± SD) of images shown in 
Figure 3.4. *These numbers are statistically different from treatment with BPD (p < 0.05). 
[Adapted from Photochem. Photobiol. 85, 1177-81, 2009] 
 
DFO is known to quench hydroxyl radical formation generated via the Fenton 
reaction (Hoe, Rowley et al. 1982; Entman, Youker et al. 1992; Faurschou and 
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Gniadecki 2008).  Analysis of intensities indicates that ~50% of the total APF 
fluorescence was derived from processes quenched equally by DFO or DMSO, 
presumably representing •OH (Table 3.2).  Adding both reagents did not further promote 
fluorescence quenching, consistent with the supposition that the fluorescence 
diminished by DMSO represents •OH.  Incubation of the cell culture with as little as 
0.1% DMSO was also found to quench the fluorescence of •OH derived APF 
fluorescence after irradiation. 
Experiments were designed to determine whether HPF might be useful for 
monitoring •OH formation during irradiation of photosensitized cells.  The interaction 
between •OH and HPF produces only 20% of the fluorescence intensity observed with 
APF (Table 3.1).  As a result, detection of a fluorescent signal from HPF after an LD90 
PDT dose would require a 5000 ms exposure.  This was associated with substantial 
photobleaching of the probe (not shown).  Since SOSG cannot be used with intact cells 
because of its inability to penetrate the cell membrane (Setsukinai, Urano et al. 2003) 
and the often-used probe DCF is readily auto-oxidized (Setsukinai, Urano et al. 2003), it 
was considered that APF or HPF might be useful for “on-line” monitoring of 1O2 
formation, in the presence of DMSO to suppress •OH formation.  A better procedure for 
assessing singlet oxygen formation, involving a new probe (DADB) was later developed. 
3.4 CONCLUSIONS 
These studies show that in the context of PDT where a very substantial 
concentration of 1O2 is formed, APF can detect this ROS and might be a useful probe 
for this purpose if DMSO is used to suppress •OH formation.  But this represents a ‘less 
than ideal’ situation and better singlet oxygen probes are clearly needed. 
APF and HPF can be used as probes for the detection of •OH and hypochlorite 
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(Franco, Panayiotidis et al. 2007; Indo, Davidson et al. 2007; Sumitomo, Shishido et al. 
2007).  It was initially reported that these probes were relatively insensitive to 1O2 
(Setsukinai, Urano et al. 2003).  However, studies indicate that, under conditions 
associated with PDT, where high levels of singlet oxygen can be formed, fluorogenic 
interactions with 1O2 can be significant, with APF substantially more sensitive to 1O2 than 
HPF.  
Quenching studies, carried out in a cell-free system, indicated that 1.0% DMSO 
could suppress >90% of the APF fluorescence derived from •OH (Table 3.1) without 
affecting the signal derived from 1O2 (Figure 3.3).  The ability of concentrations of 
DMSO as low as 0.02% (not shown) to partially quench •OH, in a cell-free system, 
means that use of this agent should be minimized in any study designed to assess 
formation or effects of this ROS.  This sensitivity to DMSO was, however, reduced in 
studies carried out with intact cells (Figure 3.4).  A study with murine leukemia L1210 
cells and the photosensitizing agent BPD revealed that the use of APF in the presence 
vs. absence of DMSO might be a feasible approach for monitoring •OH formation during 
irradiation of photosensitized cells (Figure 3.4) but is clearly not ideal.  In the presence 
of DMSO, APF could be used to assess 1O2 formation during PDT, but, as is reported 
below, a better option involving the probe DADB was later developed. 
It has been proposed (Chekulayeva, Shevchuk et al. 2006) that the conversion of 
2-deoxy-D-ribose to products that react with thiobarbituric acid could be an additional 
test for •OH formation during PDT, as could a fluorescence assay involving derivatives 
of terephthalate (Saran and Summer 1999).  While these could be useful probes for 
assessing •OH formation during PDT, they would need to be evaluated for possible 
interactions with 1O2.  
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CHAPTER 4  
A ROLE FOR HYDROGEN PEROXIDE IN THE EFFICACY OF 
PHOTODYNAMIC THERAPY 
4.1 INTRODUCTION 
Promotion of PDT efficacy should lead to enhanced tumor eradication.  This can 
be useful, e.g. if light penetration is impaired or the concentration of the photosensitizer 
is suboptimal.  The anti-apoptotic protein Bcl-2 is a known target for PDT, and adding 
Bcl-2 antagonists can promote photokilling at low PDT doses (Kessel 2008).  PDT can 
also lead to enhanced autophagy, a survival process that can offer protection from 
photodamage, resulting in a “shoulder” on the dose–response curve (Kessel and Arroyo 
2007).  In this study, the role of H2O2 formed during PDT was examined as a factor in 
the phototoxic response.  These studies were carried out in P388 murine leukemia cells, 
using BPD as the photosensitizing agent. BPD is known to catalyze an apoptotic 
response (Granville, Levy et al. 1997) to PDT.  During the photodynamic process, a 
variety of ROS are produced, including 1O2, H2O2 and •OH (Girotti 1998). 
Two procedures were used to modulate intracellular H2O2 levels during irradiation 
of photosensitized cells.  Both involved altering the level of intracellular catalase activity.  
This enzyme is involved in the predominant detoxification pathway for H2O2, catalyzing 
its conversion to H2O + O2.  Catalase activity can be inhibited by the irreversible 
antagonist 3-amino-1,2,4-triazole (3-AT).  An exogenous cell-permeable catalase 
derivative was also used to enhance H2O2 degradation: the enzyme analog termed 
CATSKL efficiently traffics to the peroxisome, where catalase activity normally resides 
(Terlecky, Koepke et al. 2006; Koepke, Nakrieko et al. 2007; Terlecky and Koepke 
2007).  Analysis of the intracellular H2O2 concentration was provided by the fluorescent 
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probe DHR (Crow 1997; Qin, Lu et al. 2008), a product that is converted to a fluorescent 
analog upon oxidation by H2O2.  Other analytical procedures were used to monitor 
catalase concentrations and activity, phototoxicity and apoptosis, a common death 
mode after PDT.  A reaction between H2O2 and ferrous iron results in the formation of 
the highly reactive hydroxyl radical.  This reaction was first described by Fenton (Fenton 
1984):  
Fe+2 + H2O2 → Fe+3 + OH− + •OH 
To decrease the conversion of H2O2 to •OH, 2,2′-bipyridyl (BIP) was used to chelate 
Fe+2 (Breuer, Epsztejn et al. 1995) and thereby antagonize the Fenton reaction. 
4.2 MATERIALS AND METHODS 
4.2.1 Chemicals and Reagents 
Refer to section 2.2.1 for any chemicals and reagents used in this study.  Amino 
acids, tissue culture media and chemicals were purchased from Sigma-Aldrich (St. 
Louis, MO); sterile horse serum was provided by Atlanta Biologicals (Laurenceville, 
GA); DEVD-R110 by Molecular Probes (Invitrogen; Eugene, OR). Terlecky’s group has 
developed a modified catalase preparation (CATSKL) that can serve as an endogenous 
source of catalase (Terlecky, Koepke et al. 2006; Terlecky and Koepke 2007). CATSKL 
was engineered to contain both a cell penetrating peptide (CPP) to allow the enzyme to 
be rapidly endocytosed into cells, and a peroxisomal targeting signal (PTS), that targets 
the catalase directly to the peroxisomal membrane. 
4.2.2 Cell culture 
See section 2.2.2 for details on P388 cell culture maintenance. 
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4.2.3 Photodynamic studies in cell culture 
Photosensitization of cell cultures was previously described in section 2.2.5. 
CATSKL or 3-AT was present during the loading incubation when specified. 
4.2.4 Survival measurements 
Clonogenic assays were used to determine PDT efficacy. P388 cells were 
photosensitized as described in section 2.2.5, then irradiated (20–200 mJ cm−2).  Cell 
dilutions containing approximately 300 cells per 60 mm2 dishes (as determined with a 
Coulter Cell Counter) were plated on soft agar in triplicate.  After a 7- to 9-day growth 
interval, colonies were counted and their numbers compared with untreated controls.  
The plating efficiency of control (untreated) cell cultures was ~70%.  
4.2.5 BPD transport 
Cells were incubated with a 2 µM concentration of BPD for 30 min at 37°C, then 
collected by centrifugation.  Samples of supernatant fluid and the entire cell pellet were 
dispersed in a non-ionic detergent Triton X-100 (10 mM) and the resulting fluorescence 
(695–700 nm) was measured upon excitation at 400 nm.  The distribution ratio could 
then be determined.  The distribution ratio represents the ratio of [BPD 
concentration/mg cells]/[BPD concentration/µl media].  Effects of concurrent treatment 
with 3-AT, BIP or CATSKL were also assessed.  
4.2.6 BPD localization 
Cells were examined by fluorescence microscopy after incubation with 2 µM BPD 
for 30 min at 37°C (400 ± 20 nm excitation, measuring fluorescence at wavelengths 
>650 nm. Where specified, 3-AT (30 mM) or CATSKL (1000 U) was also present. 
4.2.7 Fluorescence microscopy 
Fluorescence images were acquired using a Nikon Eclipse E600 microscope and 
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a CoolSnap HQ CCD camera (Photometrics, Tucson, AZ).  Images were subsequently 
processed using MetaMorph software.  For photographs shown in Figure 4.2, a stack of 
20 images was acquired using a Prior ProScan Z-drive.  These were subject to 3-D 
deconvolution using AutoQuant Deblur software (Media Cybernetics Inc., Bethesda, 
MD). 
4.2.8 Chromatin labelling 
To assess apoptotic chromatin in cell nuclei, P388 cells were incubated with 1 
µM HO33342 (HO342) for 5 min at 37°C, washed once and examined by fluorescence 
microscopy using 360–390 nm excitation; 400–450 nm emission. 
4.2.9 Fluorimetric detection of H2O2 in cell culture 
P388 cell suspensions (2 × 106 cells mL−1) were incubated for 30 min at 37°C 
with 2 µM BPD + 5 µM DHR along with (as specified) 3-AT (30 mM), 1000 U of pure 
recombinant CATSKL (provided as a solution containing 148,000 U mg−1 protein) or 2 µM 
BIP.  The cells were then resuspended in fresh medium, adding back 3-AT, CATSKL or 
BIP if initially present.  The cells were irradiated at 15°C (690 ± 10 nm, 100 mJ cm−2).  
Fluorescence of the DHR oxidation product was measured using a multi-channel 
analyzer using 490 nm excitation and recording fluorescence at 525 nm. Fluorescence 
intensity of DHR alone was < 100 units for all dark controls.  
The fluorogenic interaction between H2O2 and DHR could also be measured in 
real time during irradiation using an SLM 48000 series fluorometer.  Cell cultures were 
prepared as outlined above, then resuspended in 3 mL of fresh medium in 1 × 1 × 3 cm 
glass cuvettes.  The temperature was maintained at 20°C by a Peltier system and the 
contents stirred. Irradiation was carried out using light from a 690 nm diode laser (1 mW 
cm−2) directed at the top surface of the cuvette via a 400 µ fiber, using a GRIN (graded-
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index) lens to focus the beam to a 0.9 cm diameter circle.  Fluorescence emission from 
oxidized DHR (525 nm) was monitored using 490 mn excitation.  The “slow kinetic” 
mode was used for data acquisition with points collected every 4 s for 180 s. Influence 
of 690 nm irradiation on the emission photomultiplier detector was eliminated by 
insertion of a 550 nm low-pass filter into the emission beam. 
4.2.10 DEVDase assays 
Cells were incubated as outlined above, irradiated as specified, then lysed in 100 
µL of buffer containing 50 mM Tris pH 7.2, 0.03% Nonidet P-40 and 1 mM DTT. The 
lysates were briefly sonicated and debris removed by centrifugation (10,000 g for 1 
min).  The supernatant fluid (50 µL) was mixed with 40 µM DEVD-R110, 10 mM HEPES 
pH 7.5, 50 mM NaCl and 2.5 mM DTT in a total volume of 100 µL.  The rate of 
increased fluorescence emission, resulting from the release of rhodamine-110 from the 
fluorogenic substrate (Cai, Zhang et al. 2001), was measured over 30 min at room 
temperature using a Fluoroskan Ascent fluorescent plate reader. DEVDase activity is 
reported in terms of nmol product min-1mg-1 protein.  Control determinations were made 
on extracts of untreated cells.  Each assay was performed in triplicate.  The Lowry 
method was then used to determine protein concentrations. 
4.2.11 Catalase activity 
Catalase activity was monitored by spectrophotometry.  Activity is defined in 
terms of conversion of H2O2 to H2O + O2; this results in the loss of H2O2 absorbance at 
240 nM.  One unit of catalase is defined as the amount needed to convert 1.0 mol of 
H2O2 to O2 + H2O per minute at pH 7.0 and 23°C.  In initial studies, cell extracts (40 µL) 
were added to quartz cuvettes containing 3 mL of 50 mM phosphate buffer pH 7.0 and 
20 mM H2O2.  The initial optical density was ~0.5.  Loss of absorbance was then 
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determined over 30 s intervals.  Since precise timing of short intervals can be 
inaccurate, loss of H2O2 was more accurately determined by a colorimetric assay 
involving a product formed from peroxide and acidified titanium sulfate (Fujimoto 1965; 
Storrie and Madden 1990).  After incubating a mixture of H2O2 + cell lysate for 30 min at 
room temperature, a solution of TiOSO4 in 1 N H2SO4 is then added, with the optical 
density at 405 nm measured 15 min later.  
4.2.12 Western blot analyses 
Conversion of procaspase-3 to the active form, along with the ability of CATSKL to 
enhance the catalase level in P388 cells was assessed via Western blots of whole cell 
lysates.  After specific treatments, P388 cell cultures were lysed in BD BaculoGoldTM 
Insect Cell Lysis Buffer (BD Biosciences, San Jose, CA).  The samples were then 
centrifuge at 10,000 g for 1 min to remove any debris and the Lowry method was used 
to determine the protein concentration of the samples.  The lysates were diluted with 
SDS-PAGE buffer adjusting for protein concentration, and heated to 85°C for 5 min. 
Aliquots containing 40 g of protein were subjected to electrophoresis on 4–20% tris-
glycine gels (life Technologies, Carlsbad, CA) and the proteins transferred to 
polyvinylidene fluoride membranes.  Nonspecific antibody binding was blocked by 
incubating the membranes in 5% membrane blocking agent in TBS-T for one hour on a 
rotator at room temperature. The membranes were washed three times for five minutes 
each with TBS-T and then incubated with the primary antibodies for one hour.  Anti-
mouse/human antibodies to caspase-3 and catalase were obtained from BD 
Pharmingen (San Jose, CA).  After incubation with the primary antibodies, the 
membranes were subsequently washed again, followed by one-hour incubation with an 
alkaline phosphatase-linked secondary antibody at room temperature (Amersham ECF 
37 
 
Western Blotting Reagent Kit, GE Healthcare, UK).  A proprietary substrate is then 
cleaved by phosphatase activity to form a fluorescent product that could be detected 
with the using a Storm imaging system (Molecular Dynamics) and quantified using the 
ImageJ analysis program.  Actin analysis was carried out to insure equal loading of 
proteins.  
4.2.13 Statistical Analyses 
A paired one-tailed t-test was used to analyze data shown in Table 4.1.  This 
method was also used to analyze apoptotic nuclei in Figure 4.3. 
4.3 RESULTS AND DISCUSSION 
4.3.1 PDT dose–response information 
The effect of varying the light dose on BPD-induced phototoxicity, assessed by 
clonogenic studies, is shown in Figure 4.1.  This demonstrates the fairly steep dose–
response curve typical of PDT.  A 50% loss of viability occurred at a light dose of ~60 
mJ cm−2. Effects of selected additions are shown in Table 4.1 and described in section 
4.3.5. 
Figure 4.1	  P388 cells were photosensitized with 
BPD (2 µM) and irradiated at varying light doses. 
Viability was determined by clonogenic assays. 
Similar results were observed in a second 
independent experiment. [Adapted from 
Photochem. Photobiol. 85, 1491-6, 2009] 
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4.3.2 BPD transport 
Incubation of cells with a 2 µM concentration of the photosensitizer BPD resulted 
in a drug distribution ratio of 21.4 ± 1.5. This was not affected by the presence of 3-AT, 
BIP or CATSKL at concentrations specified in the legend to Table 4.1.  
4.3.3 BPD localization 
The pattern of BPD localization suggests affinity for mitochondria >> ER. This is 
consistent with data shown previously (Runnels, Chen et al. 1999).  This pattern was 
not altered when cells were incubated with BPD + 3-AT or CATSKL (Figure 4.2) or BIP 
(data not shown). 
 
Figure 4.2 Fluorescence microscopy demonstrating the localization of BPD in P388 
cells. Cells were incubated with a 2 µM concentration of the sensitizer for 30 min at 
37°C and images acquired as described in the text. a = BPD alone; b = BPD + 30 mM 
3-AT; c = BPD + 1000 U CATSKL. Photographs are representative of observations for 
three independent experiments. [Adapted from Photochem. Photobiol. 85, 1491-6, 
2009]	  
4.3.4 Effects of 3-AT and CATSKL in the dark 
While 3-AT and CATSKL had significant effects on catalase activity in control cells, 
neither induced activation of DEVDase.  A significant change in levels of H2O2 was not 
detected in cells kept in the dark with these agents as well (Table 4.1, columns 2–4), as 
shown by the absence of significant DHR oxidation to a fluorescent product. 
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4.3.5 Catalase modulation and PDT-induced effects 
An LD90 PDT dose resulted in a significant degree of DEVDase activation 30 min 
after irradiation of photosensitized cells.  This was enhanced by 3-AT and impaired with 
CATSKL.  The overall level of catalase activity was not significantly altered by PDT.  The 
presence of the ferrous iron-chelating agent BIP resulted in a decrease in the level of 
DEVDase activity and in the LD50 light dose, suggesting a phototoxic effect of •OH, 
derived from H2O2, thereby enhancing the pro-apoptotic effect of PDT (Table 4.1).  In 
agreement with the DEVDase data (Table 4.1), addition of CATSKL decreased numbers 
of apoptotic nuclei 60 min after irradiation, while addition of 3-AT had the opposite effect 
(Figure 4.3).  Numbers of apoptotic nuclei determined in three such fields indicated >1% 
in untreated cells, 58 ± 4% in cultures after PDT, 31 ± 5% in cells treated with PDT in 
the presence of CATSKL and 88 ± 3% in cells treated with PDT + 3-AT.  Incubation with 
these agents offered a significant degree of protection (CATSKL) or promotion (3-AT) of 
phototoxicity as determined by paired one-tailed t-tests (p < 0.05).  
Table 4.1 Effects of CATSKL and 3-AT on PDT efficacy 
 Controls*  Irradiated cells† 
Assay  + 3-AT + CATSKL   + 3-AT + CATSKL + BIP 
DEVDase 0.3 ± 0.1‡ 0.4 ± 0.07 0.3 ± 0.09  5.1 ± 1.2 7.6 ± 1.3 3.9 ± 1.3 4.5 ± 0.9 
Catalase 6.23 ± 0.42§ 0.93 ± 0.12 26.2 ± 1.3  6.12 ± 0.62 0.99 ± 0.17 24.4 ± 0.84 5.8 ± 0.4 
DHR < 100|| < 100 < 100  953 ± 25 2053 ± 41 356 ± 14 901 ± 34 
LD50     61 ± 3¶ 47 ± 2 72 ± 3 66 ± 4 
Effects of CATSKL and 3-AT on PDT efficacy. Data represent the mean ± SD for three independent 
experiments. * Cells were incubated for 30 min with no additions or in the presence of 30 mM 3-AT or 
1000 U of CATSKL; † Cells were incubated with 2 µM BPD plus specified additions (30 mM 3-AT, 1000 U 
of CATSKL or 2 µM BIP) for 30 min, then irradiated using an LD90 PDT dose; ‡ nmol product min-1 mg-1 
protein; § µmol H2O2 metabolized min-1mg-1 protein; || Relative fluorescence; ¶ Light dose (mJ cm-2) 
required for a 50% decrease in viability. [Adapted from Photochem. Photobiol. 85, 1491-6, 2009] 
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Figure 4.3 Effects of PDT on P388 chromatin as indicated by HO342 labelling using 
fluorescence microscopy. a = control (untreated) cells; b–d = cells 60 min after receiving 
an LD90 PDT dose; c = 1000 U of CATSKL present; d = 30 mM 3-AT added as specified 
in the text. Photographs are representative of observations for three independent 
experiments. [Adapted from Photochem. Photobiol. 85, 1491-6, 2009] 
An increase in DEVDase activity is expected to be accompanied by conversion of 
procaspase-3 to the active form. Western blot analysis of (Figure 4.4) confirmed this 
assumption. Using LD50 and LD90 PDT doses, it was determined that 3-AT increased 
the conversion of procaspase-3 (32 kDa) to the active form (17 kDa). ImageJ analysis of 
the caspases-3 bands showed that the intensity was >2 fold greater when 3-AT was 
present during the irradiation step (Table 4.2).  
 
Figure 4.4 Activation of procaspase-3. Extracts were prepared 30 min after irradiation. 
A, controls (dark); B–E, cells treated with 2 µM BPD and irradiated (60 mJ cm−2: B, C; or 
100 mJ cm−2: D, E). 3-AT was present in (C) and (E). Similar results were obtained in a 
second independent experiment. [Adapted from Photochem. Photobiol. 85, 1491-6, 
2009] 
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Table 4.2 ImageJ analysis of procaspase-3 conversion to caspases-3 
 
 
 
 
 
4.3.6 Intracellular catalase activity enhanced by CATSKL 
A western blot analysis was used to confirm that treatment of P388 cells with 
1000 U of CATSKL led to an increased intracellular level of catalase (Figure 4.5). ImageJ 
analysis confirms that there was substantial increase in intracellular catalase protein 
after 30 min, and only a slight additional increase when the incubation time was 
prolonged to 60 min (Table 4.3). 
 
Figure 4.5 Western blots for catalase showing control levels (A) and enhanced 
intracellular levels of the protein after treatment of P388 cells with CATSKL (1000 U/ 5 
mg of cells) for 30 min (B) or 60 min (C) at 37°C. Similar results were obtained in a 
second independent experiment. [Adapted from Photochem. Photobiol. 85, 1491-6, 
2009] 
Table 4.3 ImageJ analysis of CATSKL levels in P388 western blot 
 Control 30 min 60 min 
CATSKL  0.13 1.02 1.17 
Values are expressed as the ratio of catalase / actin. 
4.3.7 Detection of hydrogen peroxide in cell cultures 
Exposure of DHR to H2O2 results in it’s conversion to a fluorescent product, a 
reaction that is greatly enhanced in the presence of peroxidases (Henderson and 
 control 60 mJ cm−2 100 mJ cm−2 
  + 3-AT + 3-AT 
 A B C D E 
Procasp-3 0.647 0.836 0.667 0.815 0.321 
Caspase-3 0.006 0.168 0.377 0.261 0.618 
Values are expressed as ratio of procaspase-3 and caspase-3 signals to actin signal.  
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Chappell 1993).  The system used was not sufficiently sensitive to detect H2O2 in control 
P388 cells, but could readily detect fluorescence produced directly after irradiation 
(Table 4.1).  This fluorescence was significantly enhanced by the presence of 3-AT and 
decreased when CATSKL was used to enhance the catalase concentration.  Iron 
chelation and the resulting blockage of •OH formation by BIP did not have a statistically 
significant effect on DHR fluorescence.  These data were obtained using a multichannel 
analyzer and CCD device, permitting acquisition of fluorescence emission spectra 
averaged over 2 s.  Fluorescence at the emission maximum (525 nm) was recorded.  A 
different detection system was used to monitor the fluorogenic effect of PDT on DHR 
oxidation.  Data shown in Figure 4.6 were obtained during the irradiation of 
photosensitized cell cultures and show effects of prior treatment with 3-AT or CATSKL.  
The fluorogenic reaction was enhanced by treatment with 3-AT and impaired after 
exposure of cells to CATSKL.  Data were acquired as a function of time, using a 
photomultiplier detector in the single-photon mode. Excitation = 490 nm; emission was 
monitored at 525 nm every 4 s using 0.3 s time interval for each data point. 
Figure 4.6 Fluorogenic effect of PDT on 
DHR oxidation. Fluorescence of P388 cells 
loaded with 1 µM DHR + 2 µM BPD (with 
30 mM 3-AT or 1000 U of CATSKL present 
where specified) and irradiated at 690 nm 
for 360 s. During this time, the 
fluorescence signal from oxidized DHR at 
525 nm was acquired using 490 nm 
excitation. These curves represent data for 
a typical experiment. Essentially the same 
patterns were obtained during two 
repetitions of this study. [Adapted from 
Photochem. Photobiol. 85, 1491-6, 2009] 
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4.3.8 Statistical treatment 
Using paired one-tailed t-tests (with a sample population of 3 for all calculations) 
indicates that (1) in controls, treatment with either with 3-AT or CATSKL significantly 
altered catalase activity from the control levels (p < 0.05), and (2) incubation with 3-AT 
and CATSKL significantly altered DEVDase activity, catalase activity, DHR fluorescence 
and the LD50 dose from the values obtained with PDT alone (p < 0.05).  Moreover, the 
addition of BIP had no significant effect on any PDT-induced parameter.  Chelation of 
ferrous ion appears to offer some protection from phototoxicity and decrease in 
DEVDase activity, but these effects did not reach the 95% confidence level. 
4.4 CONCLUSIONS 
The dose–response curve for BPD-PDT (Figure 4.1) demonstrated that even a 
small increase in light dose can cause a substantial increase in phototoxicity. Causing 
such an increase by manipulating H2O2 formation is therefore a possibility to be 
considered. 
Apoptosis is an irreversible process leading to cell death, and has been shown to 
be a predominant form of direct cell kill after PDT (Oleinick, Morris et al. 2002).  Singlet 
oxygen is widely assumed to be the initial toxic ROS produced during PDT with most of 
the current photosensitizing agents in clinical use.  A recent report (Kim, Rodriguez et 
al. 2008), using only a photosensitizer + cytochrome c, indicated that there were 
oxidation products that could not be explained by the action of 1O2 alone.  While a 
solution containing a photosensitizer and a protein may not accurately mimic the 
conditions that occur in cells or tissues, results reported in this study indicate that even 
in a simple system, multiple ROS can be detected. Kochevar et al. (2000), using HL-60 
cells, found that altering irradiation conditions such that rose bengal produced either 1O2 
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or radical species, resulted in apoptosis only under the former conditions.  Assuming 
that this effect may also be pertinent to the cell line and photosensitizing agent used 
here, radical-initiated photodamage may be an inefficient method for inducing 
apoptosis, but might amplify the phototoxic effect(s) of 1O2. [note: that later studies 
showing WST11 to be less efficient than NPe6 is consistent with this supposition]. 
Figure 4.3 demonstrates that the apoptotic response to PDT is enhanced by 3-
AT and decreased when the intracellular concentration of catalase is enhanced. 
Changes in the apoptotic response were reflected in the conversion of procaspase-3 to 
the active form (Figure 4.4).  Additional studies were carried out with BIP, a reagent that 
chelates Fe+2 and is therefore expected to antagonize formation of •OH via the Fenton 
reaction. These data are summarized in Table 4.1. 
The ability of the CATSKL preparation to augment the cellular level of catalase 
was demonstrated by studies involving Western blot analysis.  In the context of these 
studies, it is important to consider that CATSKL was specifically designed as an 
exogenous source of catalase activity that would migrate to the peroxisome where this 
enzyme is normally found (Terlecky, Koepke et al. 2006; Koepke, Nakrieko et al. 2007; 
Terlecky and Koepke 2007).  Use of unmodified catalase will result in the appearance of 
enzyme activity in the cytosol where it is normally not found, with possible effects on 
signalling pathways or other anomalous changes in cell biology.  
Using the fluorescent probe DHR, an estimation of H2O2 formation was obtained 
during irradiation of photosensitized P388 cells (Figure 4.5).  The increase in 
fluorescence intensity was impaired by the presence of CATSKL and enhanced in cells 
previously treated with 3-AT.  Fluorescence values shown in Figure 4.5 were measured 
with a photomultiplier-based fluorometer that permits data accrual at a single 
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wavelength, while results shown in Table 4.1 were obtained with a multichannel 
analyzer and a CCD camera.  The numerical values are therefore different but the 
overall trends are consistent with interpretations. 
In these studies, there was no significant alteration in the level of catalase activity 
when photosensitized cells were irradiated.  This differs from results reported by (Luo, Li 
et al. 2006) who observed a significant decrease when keratinocytes were treated with 
Photofrin and then irradiated.  This result could be attributed to the fact that Photofrin is 
a complex mixture of porphyrin monomers, dimers and higher oligomers that may 
localize quite differently than BPD.  
Hydrogen peroxide can promote autophagy (Scherz-Shouval, Shvets et al. 2007) 
via oxidation of an amino acid on one of the proteins involved in the autophagic 
process.  Since autophagy is expected to protect cells from low-dose PDT (Kessel and 
Arroyo 2007), enhanced autophagy resulting from H2O2 formation might be expected to 
decrease overall PDT efficacy, although results shown in Table 4.1 indicate otherwise.  
Further studies using cell lines lacking the capacity for autophagy might provide further 
information on the potential role of H2O2-induced autophagy in the overall phototoxic 
effect.  
What conclusions can be drawn from these studies?  Verma, Watt et al. (2007) 
proposed new strategies for promotion of PDT efficacy.  One involves combination 
therapy with a view toward increasing susceptibility of cells to PDT.  It had previously 
been shown that concurrent treatment with PDT + Bcl-2 antagonists resulted in 
enhanced photokilling (Kessel 2008).  The present study suggests that, in addition to 
the effects of 1O2 on such critical targets as anti-apoptotic Bcl-2 family proteins (Kim, 
Luo et al. 1999; Xue, Chiu et al. 2001) and on lysosomes (Reiners, Caruso et al. 2002), 
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H2O2 formed during PDT may also play a role in photokilling.  As indicated by Figure 
4.1, any phenomenon that produces even a minor promotion in PDT efficacy can have a 
marked effect on tumor eradication. 
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CHAPTER 5  
EVALUATION OF DIETHYL-3-3’-(9,10-ANTHRACENEDIYL)BIS ACRYLATE AS A 
PROBE FOR SINGLET OXYGEN FORMATION DURING PHOTODYNAMIC 
THERAPY 
5.1 INTRODUCTION 
Singlet oxygen has been considered the predominant cytotoxic product formed 
during PDT (Weishaupt, Gomer et al. 1976; Thomas, Hall et al. 1987; Niziolek-Kierecka, 
Pilat et al. 2010).  The ‘classic’ method for monitoring 1O2 formation involves the 
detection of 1270 nm phosphorescence using a detector cooled to 77 K.  This requires 
equipment not routinely available in many laboratories.  Electron spin resonance (ESR) 
can also be used in conjunction with appropriate spin traps, but this can be unwieldy for 
studies involving cell culture.  A variety of fluorescent probes have been identified that 
can detect different ROS, but the specificity is often less than is advertised (Bartosz 
2006; Price and Kessel 2010; Zielonka and Kalyanaraman 2010).  The fluorescent 
probe APF, initially designed to detect •OH (Setsukinai, Urano et al. 2003), can also 
detect the high concentrations of 1O2 produced during PDT (Price, Reiners et al. 2009).  
But APF is also highly-sensitive to •OH, so it does not represent an ideal singlet oxygen 
probe.  
A more selective probe for 1O2 detection is SOSG, but this agent is unable to 
penetrate cell membranes (Flors, Fryer et al. 2006).  Ogilby’s group reported a 
procedure for promoting cellular uptake of SOSG, but reported that the ability of the 
probe to detect 1O2 formation during PDT was unreliable (Gollmer, Arnbjerg et al. 2011).  
It is possible that this problem arose from their choice of the photosensitizing agent, the 
tetra cationic porphyrin TMPyP.  This agent was reported to concentrate in nuclei 
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(Tada-Oikawa, Oikawa et al. 2009) and the extent of penetration of SOSG into nuclei is 
unknown.  
A recent report has indicated the synthesis of a cell-permeable probe for 1O2 
(Oliveira, Severino et al. 2011).  This anthracene derivative, termed diethyl-3-3’-(9,10-
anthracenediyl)bis acrylate (DADB), was both highly selective for 1O2 and able to cross 
the plasma membrane.  Unlike many other ROS probes, the fluorescence of DADB is 
reduced by the formation of an endoperoxide when exposed to 1O2.  
Experiments were designed to examine the ability of DADB to detect ROS 
formed by a group of photosensitizing agents with different sites of sub-cellular 
localization.  Effects of two lysosomal photosensitizers with differing patterns of ROS 
formation were compared: the chlorin NPe6 and the palladium bacteriopheophorbide 
WST11 (Mazor, Brandis et al. 2005).  NPe6 is known to have a high 1O2 yield upon 
irradiation (Spikes and Bommer 1993; Spikes and Bommer 1993), whereas WST11 
produces mainly oxygen radicals upon irradiation in a relatively aqueous environment 
(Ashur, Goldschmidt et al. 2009). 
5.2 MATERIALS AND METHODS 
5.2.1 Chemicals and Reagents 
NPe6 was provided by Prof Kevin M. Smith, Louisiana State University. BPD was 
purchased from VWR, mTHPC was obtained from Frontier Scientific and WST11 was 
prepared as described in (Brandis, Mazor et al. 2005). Refer to section 2.2.1 for other 
photosensitizers used.  The synthesis of DADB was carried out as indicated in (Oliveira, 
Severino et al. 2011) with a minor alteration: the reaction mixture (dibromoanthracene + 
ethylacrylate) was maintained at 110°C for only 8 h without affecting the yield of 
product.  
49 
 
5.2.2 Cell culture 
Murine hepatoma Hepa 1c1c7 cells were initially obtained from Dr. JP Whitlock 
Jr, Stanford University and provided by Dr. J. Reiners, Jr.  These cells were maintained 
in αMEM (Sigma–Aldrich, St. Louis, MO) supplemented with 5% fetal bovine serum and 
antibiotics in a 5% CO2 atmosphere, at 37°C.  
5.2.3 Photodynamic studies in cell culture 
1c1c7 cells were cultured on 22 mm glass cover slips in 5% CO2.  PDT studies 
were carried out after incubation with 1 µM WST11 for 16 h, 0.5 µM BPD for 1 h, 20 µM 
NPe6 for 1 h or 0.5 µM mTHPC for 16 h, all at 37°C. The medium was then replaced 
and the cells irradiated.  The light source was a 600 W quartz-halogen lamp with IR 
radiation attenuated by a 10 cm layer of water and further limited by interference filters 
(±10 nm). Irradiation took place at a temperature of 15°C to inhibit initiation of apoptosis.  
Concentrations of the photosensitizers were adjusted so as to produce a 90% 
photokilling by a 270 mJ cm-2 light dose.  The wavelengths of irradiation were 750 nm 
(WST11), 690 nm (BPD) and 660 nm (mTHPC and NPe6).  During the final hour of the 
photosensitizer loading incubation, DADB was added (10 µM).  LD90 doses for the 
photosensitizers employed in this study were established by clonogenic studies. 
Fluorescence images were acquired directly after irradiation. 
5.2.4 Phase-contrast and fluorescence microscopy.  
Images were acquired with a Nikon E-600 microscope using a Rolera EMCCD 
camera (QImaging, Surrey, BC, Canada).  DADB fluorescence centered at 525 nm was 
determined using 360–400 nm excitation.  A 600 nm low-pass filter was inserted into the 
emission path to eliminate fluorescence emission from the photosensitizing agents.  The 
acquisition time for each fluorescence image was 100 ms.  The resulting images were 
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acquired and analyzed using the ‘region statistics’ program (MetaMorph, see section 
3.2.9).  Data are reported in terms of average pixel density ± SD for images involving at 
least 30 cells. Additional studies were carried out to assess the variation of this value in 
replicate images. 
5.2.5 Oxidation of DADB.  
To assess the stability of DADB to irradiation during fluorescence microscopy, 
stability of this agent to the light used in image acquisition was first assessed.  Two 
successive 100 ms exposures were used to determine whether there was a loss of 
fluorescence after a 100 ms exposure to exciting light on the stage.  As an additional 
stability test, cells loaded with DADB were exposed to exciting light for 15 s, and an 
image acquired.  This is far longer than the 100 ms exposure time, and provided an 
estimate of probe stability to the UV excitation beam.  The next experiment involved the 
determination of the ability of photosensitizers to alter DADB fluorescence.  This was 
carried out by measuring the change in pixel brightness as a result of irradiation of 
photosensitized cells containing DADB.  
5.2.6 Statistical analyses 
To determine any significance of the effects of PDT on DADB fluorescence, 
unpaired one-tailed t-tests were run using the mean ± SD of the pixel intensity and the 
number of cells in the field as the sample size, n, for standardization. 
5.3 RESULTS AND DISCUSSION 
5.3.1 DADB: labelling pattern 
Incubation of 1c1c7 cells with 10 µM DADB for 60 min led to a labelling pattern 
that appears to involve intracellular membranes (Figure 5.1).  The fluorescence labelling 
pattern did not appear to involve any specific organelle population, although nuclear 
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labelling was negligible. 
 
Figure 5.1	   Phase-contrast (a) and fluorescence images (b and c) showing the 
localization of DADB in 1c1c7 cells following a 1 h incubation with a 10 µM DADB 
concentration. Panel (c) is an enlargement of the lower left portion of panel (b). 
Photographs are representative of observations for three independent experiments. 
[Adapted from Photochem. Photobiol. 88, 717-20, 2012] 
5.3.2 Intrinsic DADB oxidation 
Mammalian cells are known to form ROS, including 1O2, during UV irradiation 
(Tyrrell and Pidoux 1989).  To examine the effect of image acquisition on DADB, cells 
were used that had been incubated with the probe alone. No significant decrease in the 
fluorescence signal was observed after a 100 ms exposure interval (c.f. Figure 5.2 a, b; 
Figure 5.4).  A decrease in fluorescence was, however, detected when cells loaded with  
 
Figure 5.2 Fluorescence intensity of intracellular DADB as a function of the time of 
exposure of cells to illumination on the microscope stage (380– 400 nm). Panels (a and 
b) represent two sequential exposures of 100 ms each, to test for photobleaching during 
image acquisition. Panel (c) showed the image captured by a 100 ms exposure after 15 
s of irradiation on the microscope stage. Photographs are representative of 
observations for three independent experiments. [Adapted from Photochem. Photobiol. 
88, 717-20, 2012] 
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DADB cells were exposed to UV light from the excitation source on the microscope 
stage for 15 s before image acquisition (Figure 5.2 c; Figure 5.4).  
5.3.3 Effects of varying the ROS on DADB fluorescence 
Both NPe6 and WST11 localize in lysosomes, but produce different ROS upon 
irradiation (Kessel and Price 2012).  An LD90 PDT dose led to a barely detectable effect 
on DADB fluorescence when WST11 was employed (Figure 5.3, C).  In contrast, a 
significant loss of DADB fluorescence was observed with NPe6 (Figure 5.3, D), an 
agent known to produce a substantial 1O2 yield upon irradiation (Spikes and Bommer 
1993).   A ‘region statistics’  analysis  (see section 3.2.9) of  pixel  brightness  in   these  
Figure 5.3 Effect of ROS 
formation on DADB fluorescence: 
(A) background fluorescence of 
cells; (B) control DADB 
fluorescence; (C) DADB 
fluorescence following an LD90 
PDT dose using WST11; (D) a 
similar study with NPe6. 
Photographs are representative of 
observations for three 
independent experiments. 
 
 
 
 
 
images showed values of 22.7 ± 2.3 (background), 85.6 ± 4.8 (DADB control) 85 ± 4.7 
(PDT using WST11) and 55 ± 2.4 (NPe6). Both of the latter images were acquired using 
LD90 PDT doses.  These data indicated that NPe6, but not WST11, was associated with 
the decreased DADB fluorescence derived from singlet oxygen formation.  A more 
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detailed analysis involving other photosensitizing agents and multiple trials was then 
carried out.  
5.3.4 Loss of DADB fluorescence after PDT using different photosensitizing 
agents 
Photodynamic therapy under LD90 conditions with two other photosensitizing 
agents also led to a loss of DADB fluorescence (Figure 5.4).  For this study, mTHPC, a 
photosensitizer targets ER and golgi (Marchal, Francois et al. 2007) and BPD, an agent 
that targets mitochondria (Peng, Chang et al. 2005), were utilized. Results obtained with 
WST11 and NPe6 are also shown in this figure. The data shown represent the result of 
‘region statistics’ analysis of single images, followed by an analysis of images from 
three replicate studies where only the mean pixel brightness value ± SD was 
determined. 
Figure 5.4 DADB oxidation by singlet 
oxygen as indicated by pixel brightness. 
All acquisitions involved a 100 ms 
exposure interval. Gray bars: mean pixel 
intensity of DADB in a typical experiment 
involving 50 ± 5 control cells or cells after 
PDT. C1, C2 = two sequential images of 
the same field to test for loss of 
fluorescence during acquisition; C3 = an 
image acquired after a 15 s exposure of 
cells to the excitation beam on the 
microscope stage; NPe6, WST11, BPD, 
mTHPC = images of cells after LD90 PDT 
doses with specified photosensitizers. 
Open bars represent the mean ± SD for 
three separate experiments where only 
the mean pixel intensity of the images 
was evaluated with the SD derived from 
these values. [Adapted from Photochem. 
Photobiol. 88, 717-20, 2012] 
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5.3.5 Statistical considerations 
The grey error bars shown in Figure 5.4 represent the variation in pixel intensity 
in the cytoplasmic region of cells in the microscope field, not the variation in the mean 
value for pixel intensity for replicate determinations. The extent of the error bars indicate 
that there are subcellular regions with differing pixel brightness in all the images. This 
variation can readily be observed in a magnified image of a portion of Figure 5.1b, 
shown in panel c. This variation is typical but does not appear to detract from the utility 
of this probe. When the mean pixel density was measured in triplicate samples, the 
average value of pixel intensity showed a much smaller SD (open bars shown in Figure 
5.4) than the analysis of a single image.  
5.4 CONCLUSIONS 
DADB can monitor the formation of 1O2 by several photosensitizing agents 
regardless of their site of initial subcellular localization.  A high degree of specificity of 
DADB for singlet oxygen detection was indicated in Oliveira, Severino et al. (2011), as 
was the ability of this agent to penetrate cell membranes.  The loss of DADB 
fluorescence during PDT in a cell-free system established the ability of this agent to 
interact with 1O2, but did not provide an estimate of sensitivity in the context of PDT.  
Using BPD, mTHPC or NPe6, a similar loss of DADB fluorescence was observed at 
equitoxic PDT doses (Figure 5.4).  Qualitative comparisons are readily feasible, e.g., 
demonstrating that an LD90 PDT dose with the lysosomal targeting photosensitizer 
NPe6 produces substantially more 1O2 than did a comparable PDT dose with WST11.  
The latter also targets lysosomes (Kessel, Price et al. 2012), but produces mainly 
oxygen radicals (Ashur, Goldschmidt et al. 2009).  Other procedures for 1O2 detection 
are available, e.g., measuring the 1270 nm 1O2 signal (Baker and Kanofsky 1991).  
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Geiger, Korytowski et al. (1997) has described a chromatographic procedure that 
measures the conversion of cholesterol to a product that is uniquely formed by the 
action of 1O2.  The development of a cell-permeable fluorescent probe, if adequately 
sensitive, would place 1O2 measurements within the reach of laboratories with 
conventional fluorescence microscopy facilities.  Quantitative aspects of the analysis 
depend on how well 1O2 generated at different subcellular loci can interact with DADB 
and how well DADB can compete with biological substrates for oxidation.  There was a 
broad spectrum of pixel intensities within a single field.  The standard deviation value 
was as large as 30% of the mean in untreated cells and cells that had been 
photosensitized and irradiated (Figure 5.4).  Areas selected for the thresholding 
program showed a considerable variation in pixel intensity, but the mean pixel intensity 
measurement of several images appears to provide a reproducible indication of the 
level of probe oxidation.  An alternative approach is discussed in Oliveira, Severino et 
al. (2011): GC ⁄ MS analysis could provide an indication of DADB oxidation free from 
errors implicit in the thresholding process.  These data indicate that DADB can 
successfully be used as a fluorescence probe for singlet oxygen formation in live cells.  
Although excitation in the UV can also elicit a loss of DADB fluorescence even in the 
absence of a photosensitizing agent, the exposure times were sufficiently small so that 
this problem was avoided. 
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CHAPTER 6  
WST11 AND NPe6: EFFECTS OF OXYGENATION LEVELS ON 
PHOTOSENSITIZING EFFICACY 
6.1 INTRODUCTION 
Clinical evidence suggests tumor hypoxia can lead to resistance to both radio- 
and chemotherapy (Moulder and Rockwell 1987; Teicher 1994; Castano, Demidova et 
al. 2005; Moeller, Richardson et al. 2007).  This had led researchers to find procedures 
to improve tumor oxygenation.  The presence of dissolved oxygen in the target tissue is 
one of the primary components for treatment with PDT.  Studies have been conducted 
since the mid-1980s on the requirement for oxygen in the photokilling of cells.  Moan’s 
group showed that with HPD-sensitized NHIK 3025 cells, photosensitivity was reduced 
by 50% of its maximal effectiveness when cells were incubated and irradiated in 1% 
oxygen (Moan and Sommer 1985).  Henderson showed similar results with Photofrin II 
and RIF cells using 1% O2 (Henderson and Fingar 1987). Both articles noted that the 
treatment of tumors with anoxic regions still showed high cure rates (or favourable 
treatment outcomes) and concluded that the tumor cell inactivation in these regions 
must be the result of a mechanism(s) other than direct PDT cytotoxicity.  While 
shutdown of tumor vasculature is commonly seen with the use of several 
photosensitizers and is believed to play a role in the overall tumor destruction 
(McMahon, Wieman et al. 1994; Fingar 1996; Fingar, Kik et al. 1999), tumor cell kill in 
regions of hypoxia was attributed to an unknown secondary method (Henderson and 
Fingar 1987; Fingar, Wieman et al. 1992).  
Once it was shown that NPe6 and WST11 both localized in lysosomes but 
produced different ROS upon irradiation, a series of experiments was designed to 
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determine whether formation of singlet oxygen vs. oxygen radical species were equally 
sensitive to hypoxia. 
6.2 MATERIALS AND METHODS 
6.2.1 Chemicals and Reagents 
Refer to sections 2.2.1 and 5.2.1 for probes and photosensitizers used in these 
experiments. Nitrogen and nitrogen-oxygen mixtures were provided by Praxair. 
6.2.2 Cell culture 
See section 5.2.2 for details on the maintenance of the murine 1c1c7 cell line. 
6.2.3 Clonogenic assays 
A suspension of 1c1c7 cells was diluted so as to contain approximately 100 cells 
per 1ml of media.  Aliquots of 3 ml were then added to 60 mm2 tissue culture dishes.  
One group of dishes was then incubated at 37º C in a 5% CO2 incubator for 24 h while a 
second set was similarly incubated at 37ºC in a sealed BioSpherix incubator 
equilibrated with 5% CO2, 1% oxygen. HIF1-α upregulation was verified by western blot 
to check for hypoxic status. 
6.2.4 Photosensitization and analysis of colony formation  
Dishes from the normoxic and hypoxic incubators were then incubated with 
WST11 (2 µM, 16 hr) or NPe6 (20 µM, 1 hr), the media replaced with fresh media that 
had been equilibrated in an atmosphere of 20% or 1% oxygen, and finally irradiated for 
graded intervals (section 2.2.4). After irradiation, all dishes were returned to the 5% CO2 
incubator for 7–9 days.  
Numbers of colonies were then determined using an Oxford Optronix GelCountTM 
electronic colony counting system.  Data reported represent results obtained with 
triplicate samples and are shown as % of surviving colonies using the untreated controls 
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as 100%.  
6.2.5 Photobleaching studies 
These studies were carried out in 3 ml volumes of 10 mM phosphate buffer pH 7.  
An atmosphere of 1% oxygen was obtained by equilibrating autoclaved buffer with 99% 
nitrogen:1% oxygen for 30 min.  To achieve a minimal level of oxygen, a gas composed 
of 99.99% nitrogen was passed through a high capacity oxygen trap (RESTEK, 
Bellfonte, PA) with PVC plastic tubing used for connections to further reduce 
contamination by atmospheric oxygen. Initial optical densities at 654 nm (NPe6) or 748 
nm (WST11) were 0.100 ± 0.005. Either of two fluorescent probes, APF or SOSG, was 
present at 2 µM concentrations, where specified.  
Glass cuvettes with polished, transparent bottoms were irradiated from below 
using laser diodes (662 nm for NPe6; 750 nm for WST11) at a power of 100 mW. Under 
these conditions, a 10 second irradiation corresponds to 1 joule.  During the irradiation 
process, gas mixtures or air were constantly bubbled into the cuvette.  Photosensitizer 
spectra were obtained using a Shimadzu Biospec-1601 spectrophotometer and log of 
optimal emission was potted against time of irradiation.  The spectrum of the probe 
fluorescence was obtained using an Instaspec X CCD (Oriel/Newport) detector, with 
optimal fluorescence plotted against time of irradiation.  The optical density of the 
photosensitizer and the fluorescence of the probe were determined after irradiations for 
15 or 30 seconds. 
6.2.6 Measurement of oxygenation levels.  
Phosphate buffers equilibrated with different levels of oxygen were tested for 
levels of dissolved oxygen using the Winkler procedure (Helm, Jalukse et al. 2009).  
Triplicate assays were carried out using reagent solutions that had been equilibrated 
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with the specified oxygen mixtures. 
6.2.7 Statistical analyses and implications 
An unpaired two-tailed t-test was performed on the clonogenic data to determine 
whether the oxygenation level had a significant effect on phototoxicity.  A simple linear 
regression analysis was also performed to determine whether the different oxygenation 
conditions resulted in data that could be fitted to two regression lines or to a single line.  
The probability that the linear regression lines represented two different sets of data or 
could be derived from a single set was then calculated.  
6.3 RESULTS AND DISCUSSION 
6.3.1 Clonogenic data 
The clonogenic results obtained showed different sensitivity to the oxygenation 
level; photosensitization with WST11 showed a diminished rate of photokilling when the 
percentage of oxygen in the system was lowered from 20% to 1% (Figure 6.1, Panel A).  
The  light dose  required for a  50% loss  of viability  changed  from  180 to 360 mJ cm-2. 
Figure 6.1 Clonogenic analysis 
of murine 1c1c7 photosensitized 
with WST11 (A) and NPe6 (B). 
Cells were incubated and 
irradiated in 20% (closed circles) 
or 1% (open circles) oxygen. 
Error bars represent SD for 3 
determinations. Similar results 
were observed in a second 
independent experiment. 
	  
	  
The regression values (r2) were 0.94 (20 % oxygen) and 0.93 (1% oxygen).  Of the 
values in the chart, only those for 180 and 360 mJ cm-2 were significantly different (p < 
0.05) for the two oxygenation levels.  In contrast, with NPe6, there was no difference in 
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the degree of photokilling in 1% vs. 20% oxygen (Figure 6.1, Panel B).  Since PDT is 
carried out with a view toward maximum tumor eradication, we considered the effects at 
the higher light doses to be more pertinent indexes, or indicators of the effect of the 
oxygenation level on efficacy.  Data obtained with WST11 at 1% vs. 20% oxygenation 
was found to represent two separate regression lines at a 95% confidence level.  
6.3.2 Dissolved oxygen levels 
An analysis using the Winkler procedure indicated that buffer prepared under 
atmospheric oxygen contained 8.9 ± 0.3 mg/l of dissolved oxygen (280 µM).  Buffer 
equilibrated with 1% oxygen showed a level of 0.46 ± 0.02 mg/l of oxygen (14.5 µM).  
The analysis of buffer degassed with 99.99% nitrogen indicated an oxygenation level of 
0.005 ± 0.001 mg/l (160 nM). 
6.3.3 Photobleaching and ROS production 
Photobleaching of photosensitizing agents provides information on levels of ROS 
produced during irradiation that results in alterations in UV/VIS spectra.  Fluorescent 
probes were also used to compare rates of formation of 1O2 and •OH.  These studies 
were carried out in cell-free systems so as to provide information on photochemical 
processes that could be correlated with clonogenic photokilling data. 
The choice of fluorescent probe was dictated by prior experience with individual 
products.  DHR is responsive to a variety of ROS, but was found be unstable to light of 
almost any wavelength if the intensity was sufficiently high (as would occur during 
photobleaching studies).  A similar phenomenon has been observed with reduced DCF 
(Afzal, Matsugo et al. 2003). SOSG and APF were unaffected by light intensities used in 
these studies. 
Photobleaching and photoproduct formation were assessed by 
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spectrophotometric studies (Figure 6.2).  At the low concentration of the 
photosensitizers used here (optical density = 0.1), photoproducts were formed, as 
indicated by progressive changes in the absorbance spectra, even in 0.01% oxygen.  
Figure 6.2 Photobleaching analysis of NPe6 in (A) and (B) and WST11 in (C) and (D) 
after irradiation in buffers equilibrated with 0.01% (A, C) or 20% (B, D) oxygen. Initial 
absorbance peaks for NPe6 at 650 nm and WST11 at 750 nm both decrease during the 
subsequent irradiation periods. Similar results were observed in three independent 
experiments. 
Rates of photobleaching were assessed to provide a kinetic study (Figure 6.3).  
Panel A shows that photobleaching of NPe6 was initially linear regardless of the level of 
oxygenation (20%, 1%, 0.01%).  At the higher light doses, the fall-off in photobleaching 
can be attributed to depletion of oxygen in the system.  SOSG fluorescence formation 
under all three conditions showed a similar pattern; the initial rate was essentially 
identical regardless of the oxygenation level.  These results suggest that the excited 
state of NPe6 is very successful at scavenging even very low levels of dissolved oxygen 
to form 1O2.  In contrast, Figure 6.3(B) shows that this is not true when APF 
fluorescence was used to provide an index of •OH formation.  It appears that NPe6 
E-­‐1	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does produce •OH, but that the rate of production is affected by the oxygen 
concentration in the system.  APF can also detect 1O2 (Price, Reiners et al. 2009), but in 
view of the very high yield of 1O2 from NPe6 (Spikes and Bommer 1993), together with 
the 200-fold greater sensitivity of APF to •OH than to 1O2 (Setsukinai, Urano et al. 
2003), it appears that APF and SOSG can be used to distinguish between these 
species. It is also noteworthy that patterns of responsiveness to the oxygenation level 
for these two probes were substantially different with NPe6: the fluorogenic interaction 
with APF was much more dependent on the level of oxygenation than the interaction 
with SOSG. 
Figure 6.3 Photobleaching and fluorogenic probe analysis. A, NPe6, SOSG; B, NPe6, 
APF; C, WST11, APF. Closed circles represent photobleaching as determined by 
measuring optical density at 655 nm (NPe6) or 750 nm (WST11) as irradiation 
proceeded. Open circles show the fluorogenic effect of irradiation. Red = 20% oxygen; 
Green = 1% oxygen; Black = 0.01% oxygen. Similar results were observed in three 
independent experiments. 
WST11 proved to be more sensitive to photobleaching than NPe6 (Figure 6.3 C).  
In 20% O2, WST11 was photobleached rapidly, but even the initial rate diminished when 
the oxygenation level was decreased.  The appearance of APF fluorescence also 
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diminished in an oxygen level-dependent manner, as was observed with NPe6.  
Photobleaching of WST11 was also observed in the deoxygenated buffer and continued 
even after APF fluorescence was no longer increasing.  This result suggests that 
WST11 photobleaching independent of •OH formation can occur.  Since WST11 does 
not form singlet oxygen upon irradiation in an aqueous environment (Ashur, 
Goldschmidt et al. 2009), irradiation did not yield a fluorogenic interaction with SOSG 
(not shown). 
6.4 CONCLUSIONS 
Data shown in Figurer 6.3 indicate that the rate of photochemical reactions 
leading to the formation of •OH is more dependent on the level of oxygenation than are 
reactions that result in formation of 1O2.  The greater efficacy of NPe6 under hypoxic 
conditions is therefore associated with a minimal effect of hypoxia on singlet oxygen 
formation, and a corresponding minimal effect on photobleaching.  Formation of •OH by 
NPe6 was more sensitive to the level of oxygenation, but this species appears to play a 
minor role in photobleaching processes, and in photokilling. 
In contrast, the greater sensitivity of photokilling by WST11 to hypoxia was 
associated with a corresponding decrease in •OH formation under hypoxic conditions.  
This might be considered as a potential drawback to the use of WST11 in the clinic, but 
the current clinical protocols involve irradiation only when WST11 is still in the 
circulation.  Under such conditions, hypoxia is unlikely to be a factor. In these protocols, 
WST11 PDT leads only to vascular shutdown since an insufficient time is allowed for 
this agent to penetrate into tissues.  
The statistical treatment of data shown in Figure 6.1 indicated that the WST 
photokilling data could be represented by two different regression lines, at the 95% 
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confidence level.  In all studies involving cells, oxygen, light and clonogenic efficiency, 
there will always be intrinsic and extrinsic errors.  In order to refine the system and 
examine effects of oxygenation where the probability for error was minimal, we turned to 
photobleaching studies in a cell-free system.  These showed that production of •OH 
from either photosensitizer was more dependent on the level of oxygenation than was 
production of 1O2 from NPe6.  This result provides a mechanism for interpretation of the 
clonogenic results.  
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CHAPTER 7 
SUMMARY 
The presence of oxygen is one of the three essential components of PDT.  
Photosensitizers localize at a variety of different sub-cellular loci (Kessel 2004).  
Gorman and Rodgers (1992) proposed that ‘while photosensitizers may be restricted to 
cellular compartments, upon being generated the all-pervasive oxygen species have 
finite possibilities of contacting oxidizable targets either in the immediate area of 
generation or across an interface.’  This is only partially accurate; singlet oxygen and 
•OH will react only with substrates in their immediate vicinity.  Moan estimated that 1O2 
can diffuse at most 0.02 microns from the site of formation (Moan and Berg 1991; Moan 
and Peng 2003).  Other species, e.g. hydrogen peroxide, will likely persist for much 
longer times.  
The research shown here has revealed several new findings relating to the role 
of ROS in the direct tumor cell photokilling by PDT.  Singlet oxygen was initially 
considered as the predominant ROS formed in photosensitized cells.  There has been 
only limited consideration shown for the role(s) of the oxygen radicals and hydrogen 
peroxide in the phototoxicity of PDT. Moreover, delineation of ROS can be difficult.  
The specificity of several commercially available fluorogenic ROS probes was 
examined with a view toward providing an accessible means for testing for formation of 
different in a typical laboratory setting.  Procedures involving detection of 1270 nm 
singlet oxygen phosphorescence, or use of ESR to distinguish among ROS may be 
highly accurate, but these methods are not readily adapted to cell-culture studies and 
involve specialized (and very expensive) equipment.  The fluorescent ROS probes are 
simpler and less expensive to use, but are often assigned by their suppliers a much 
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greater specificity than can be justified.  A few probes were identified whose specificity 
in the context of PDT was suitable.  The most useful were APF (•OH >> 1O2) and DADB 
(cell-permeable and highly specific for 1O2).  SOSG, specific for singlet oxygen but 
impermeable to cells, was also useful, but only for studies in cell-free systems.  Several 
other fluorogenic ROS probes could not delineate among different reactive species in a 
cell-free system, they were therefore considered to be poor candidates for detecting 
specific ROS species in cell culture. 
Methods for altering the concentration of ROS formed during PDT may provide a 
practicable method improving the efficacy of PDT.  Superoxide might be another target 
for manipulation in future studies (see Figure 1.1); several SOD mimics and inhibitors 
have been used to alter levels of this ROS in cell culture.  In studies reported here, 
formation and destruction of hydrogen peroxide were altered with a catalase antagonist 
(3-AT) and an exogenous catalase source (CATSKL), respectively.  Studies with these 
agents permitted the demonstration of a role of this species as a factor in PDT efficacy.  
This work indicated that formation of singlet oxygen was not the sole determinant of 
PDT photokilling.  It is not clear whether H2O2 was itself the pertinent cytotoxic ROS, or 
whether this effect derives, at least in part, from subsequent conversion to •OH, a more 
reactive ROS.  Future studies in this area could be directed toward identification of a 
safe and effective short-term catalase antagonist as a means for enhancing PDT 
efficacy.  
Phototoxic properties of singlet oxygen vs. oxygen radicals were assessed using 
NPe6 and WST11.  Both localize in lysosomes but produce different ROS upon 
irradiation.  Either was effective under normoxic conditions, but NPe6 efficacy was less 
sensitive to hypoxia than was WST11.  This was traced to a correlation between oxygen 
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radical formation and the level of oxygenation that applies only to WST11.  These 
results indicate that NPe6 would be the more effective agent for direct photokilling in 
hypoxic loci.  It must, however, be noted that WST11 protocols currently involve 
irradiation while the agent is in the circulation, so this difference is not likely to affect 
efficacy.  The efficacy of sensitizers that yield only oxygen radicals upon irradiation 
could be of limited use for treating hypoxic tumors where direct cell kill is required.  In 
this regard, it is interesting to note that Moan and Sommer (1985) demonstrated that 
hematoporphyrin and HPD lost their efficacy for photokilling when the oxygen level fell 
to 1%.  It is therefore possible that NPe6 represents a class of photosensitizing agents 
that can mediate phototoxic effects even at very low oxygen levels.  
Hypoxic tumors have multiple survival pathways upregulated that may promote 
resistance to many current therapeutic modalities (Shannon, Bouchier-Hayes et al. 
2003).  PDT involving 5-ethylamino-9-diethyl-aminobenzo[a]phenothiazinium chloride 
(EtNBS) has also been shown to be useful in the treatment of ovarian tumor nodules in 
vitro under extreme hypoxic conditions (Evans, Abu-Yousif et al. 2011). EtNBS 
therefore appears to be another representative of the class of photosensitizers that, like 
NPe6, may be able to create cytotoxic ROS even at low tissue levels of oxygenation. 
Studies reported here suggest that screening and testing of photosentizers (both 
current and in development) under both normoxic and hypoxic conditions is important 
for drug development.  In this regard, it is important to remember that normal and 
malignant tissues will only rarely see an oxygenation level of 20%, the condition used 
for many tissue-culture experiments.  More pertinent results will be obtained in 
oxygenation levels more closely approximating what is found in vivo, e.g., 5% or less.	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Photodynamic therapy (PDT) is based on the ability of certain photosensitizing 
agents to selectively localize in neoplastic cells and their vasculature.  Subsequent 
irradiation at a wavelength corresponding to a photosensitizer absorbance band excites 
the photosensitizer molecules, leading to energy transfer reactions and fluorescence.  It 
was initially concluded that the phototoxic effect occurred when energy from the excited 
state of the photosensitizer was transferred to dissolved oxygen to form singlet oxygen.  
This product has a very brief half-life and will cause cellular damage only in the 
immediate vicinity of its formation.  But an excited-state photosensitizer can also interact 
with oxygen to form superoxide anion radical, which in turn (through the action of 
superoxide dismutase) is converted to hydrogen peroxide and hydroxyl radical via the 
Fenton reaction.  These reactive oxygen species (ROS) all posses properties (i.e. 
lifetime, reactivity and diffusion distances) that make them at least as cytotoxic as 
singlet oxygen. The hypothesis examined in this dissertation was that the particular 
reactive oxygen species being formed might be an important determinant of 
photodynamic therapy efficacy. 
Initial studies were designed to assess specificity of several commercially 
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available fluorogenic probes that could used for identification of ROS generated during 
PDT.  APF (for hydroxyl radical) and DADB (for singlet oxygen) were found to be useful 
for cell culture studies in the context of PDT while other probes were found to have less 
specificity than advertised. 
Using an inhibitor of catalase (3-AT) and an endogenous source of catalase that 
localizes to peroxisomes (termed CATSKL) it was feasible to alter the level of hydrogen 
peroxide produced by PDT.  Promoting persistence of hydrogen peroxide resulted in 
enhanced photokilling and vice versa.  This indicates a role for hydrogen peroxide and 
its downstream product in the photokilling process. 
The efficacy of singlet oxygen generation vs. oxygen radicals was then 
compared.  The photosensitizer NPe6 localizes in lysosomes and generates singlet 
oxygen in a high yield.  The photosensitizer WST11 also localized in lysosomes, and 
has been reported to produce only oxygen radicals upon irradiation under aqueous 
conditions.  This was confirmed by studies using the singlet oxygen probe DADB.  The 
efficacy of these photosensitizers was compared under conditions where the 
oxygenation level was varied. In cell culture, lowering the oxygenation levels from 20% 
to 1% did not alter the phototoxicity of NPe6. WST11 phototoxicity was reduced in the 
1% oxygen.  
In a cell-free system, the initial rate of formation of singlet oxygen from NPe6 was 
independent of the oxygen content. For both NPe6 and WST11, formation of hydroxyl 
was, however, highly correlated with the level of oxygenation.  
 These data indicate important roles for several different ROS that can be formed 
during PDT.  With most common photosensitizing agents, effects of singlet oxygen 
generally predominate, especially under hypoxic conditions, but in a well-oxygenated 
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system, formation of hydrogen peroxide and hydroxyl radical can also promote lethal 
photodamage.  The photosensitizing agent WST11 represents a possibly unique 
situation, where only hydroxyl radical is involved in photobleaching and tumor 
eradication.  
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